COMMITTEE ON SAFETY OF MEDICINES members declared interests

Posted November 5, 2004 · November 5, 2004

COMMITTEE ON SAFETY OF MEDICINES

http://www.mca.gov.uk/aboutagency/regframework/csm/csmhome.htm

MEMBERS HAVE DECLARED CURRENT PERSONAL AND NON-PERSONAL INTERESTS AS

FOLLOWS:

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Dr M Armitage None None

Professor D Ashby None Pfiers Statistical Talks No

Professor T R E Eli-Lilly Fees Sanofi-Synthelabo Grant Yes

CeNeS Consultancy

Pfizer Consultancy

Novartis Consultancy (clozapine)

Ms H Barnett None None

Professor A Blenkinsopp & -MS D Consultancy Servier )

Departmental Yes

Pfizer ) Research Yes

GSK ) Funding Yes

MSD ) Yes

Professor A Breckenridge None None

(Chairman)

Professor J Caldwell AstraZeneca Consultancy None

Schering-Plough Consultancy

Boots Healthcare Fees

Norton Healthcare Consultancy

Huntingdon Life Sciences Director

Pharmacia Consultancy

Amedis pharmaceuticals Director/Shareholder

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

120 C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l

a r a t i o n o f I n t e r e s t s

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Dr R Calvert None None

Dr T Chambers None None

Professor J Chipman Sci.Lucent McGhan Ltd Consultancy AstraZeneca )

Research Yes

GlaxoKline ) Grants Yes

Inamed Consultancy Syngenta Research Collaboration Yes

Professor J Darbyshire Genomyc Advisory Board Member Bristol-Myers

Squibb ) Support for Clinical Yes

GlaxoKline ) Trials eg. Salaries, Yes

Janssen Research Foundation ) running expenses, Yes

SLA Pharma, Osmetech ) consultancy, drugs, Yes

Roche ) reduced price pumps Yes

Merck ) and assays Yes

Unimed Pharmaceuticals US ) Yes

Eurpoean Society for ) Yes

Oncological & Immunological )

Research ) Yes

Gilead Sciences ) Yes

Pierre Fabre ) Yes

Pharmacia/Upjohn ) Yes

Chugai-Rhone-Poulenc ) Yes

Schering Plough ) Yes

Sanofi ) Yes

Aventis ) Yes

Wyeth & Wyeth-Ayerst ) Yes

Baxter ) Yes

Fresenius ) Yes

ML Labs ) Yes

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l a r

a t i o n o f I n t e r e s t s 121

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Professor J Darbyshire Interneuron ) Support for Clinical Yes

(continued) DuPont Pharma & Merck ) Trials eg. Salaries, Yes

Boehringer Ingelheim ) running expenses, Yes

Agouron ) consultancy, drugs, Yes

Virco ) reduced price pumps Yes

Chiron ) and assays Yes

Antisoma ) Yes

Lilly ) Yes

Intermune DSMC, Stiefel ) Yes

DSMC ) Yes

BMS Pharmacovigilance ) Yes

Professor H Dargie Servier Consultancy Merk AG Research Grant No

GlaxoKline Consultancy Novartis Research Grant Yes

Rhone-Poulenc Rorer Consultancy MSD Research Grant Yes

Chugai Consultancy Mitsubishi Research Grant Yes

Pharmacia Research Grant Yes

Meatronic Research Grant Yes

Dr M Donaghy Octapharma Honorarium for lecturing None

21 May 2001

GlaxoKline Shareholder

Professor G Duff Interleukin Genetics Inc, Scientific Advisory Board

Interleukin Genetics Inc Renewal of Yes

Boston (diagnostics Member and shares research contract

company) with Sheffield Uni.

Medical Solutions Plc, Scientific Advisory Board Shares to Sheffield

Uni.

Oxford (Mainly cancer Member and shares

diagnostics company) Stock Holding

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

122 C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l

a r a t i o n o f I n t e r e s t s

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Professor G Duff British Biotechnology Shares GlaxoKline New

Research Yes

(continued) Molecular Skincare Ltd, Shares/Director Contract with

Sheffield (Uni. of Sheffield spin- Sheffield Uni.

out company in skin research)

Dr B GlaxoKline Shares Galen Research Grant Yes

Boots Shares

Pharmacia Upjohn Fees

Professor S Eykyn None None

Dr J C Forfar GlaxoKline Shares Novartis Lecture to General No

Amersham Intl Shares Practitioners

Professor E Gordon- Bayer Plc Consultancy Chugai Research

Grants No

Toyama Europe Ltd Consultancy Amgen Research Grants No

Eli Lilly Consultancy Pfizer Research Grants No

Professor M Kendall None Menarini Dept Research Grant Yes

AstraZeneca Dept Research Grant Yes

Professor M Langman None Merck Sharpe Dohme Research support/ Yes

Consultancy

Norvartis Consultancy Yes

AstraZeneca Research Support Yes

Dr A V P Mackay None Laxendale Ltd Research Funding Lapsed

Support for a approx

consultant 1 year

colleague ago

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l a r

a t i o n o f I n t e r e s t s 123

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Professor H McGavock None None

Professor J Midgley Amylin Europe Limited ) Consultancy None

Mitsubishi Chemical (UK) )

Oxford Glycosciences )

Baxter SA )

FERX Inc )

Mallinckrodt Inc. )

Inex Pharm Corp )

Lonza Group )

Prof D Nutt GSK Consultancy/ Shareholding UCB Grant Yes

Janssen ) Consultancy GSK Grant Yes

Servier ) Wyeth Grant Yes

Esteve ) Pierre Fabre Grant Yes

Lundbeck ) Lundbeck Grant Yes

MSD )

AstraZeneca )

Wyeth ) Honoraria

Pierre Fabre )

Organon )

Professor B Park None Pfizer ) Advice Yes

Syngenta ) Yes

Glaxo Wellcome ) Yes

Professor J Petrie None None

(Co-Vice Chair)

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

124 C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l

a r a t i o n o f I n t e r e s t s

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

PDr J H Scarffe None None

Professor J F Smyth ISIS Pharmaceuticals Consultancy Novartis )

Clinical Trials Yes

Antigenics Consultancy Boehinger Mannheim ) Yes

Enchira Consultancy/ Shares British Biotech ) No

GlaxoKline Consultancy Eisai ) No

Pharma Mar Shares/ Consultancy Roche ) No

QLT Consultancy Knoll ) No

Abbott Consultancy AstraZeneca Fellowship Yes

Centocor – Non personal Clinical Trial Yes

specific

Professor T son Intercern Ltd Consultancy Abbott

Laboratories ) Fellowships

.. & Hanburys Ltd ) Meeting

Astra Respiratory ) Sponsorship

GlaxoKline ) University Yes

Merck Sharp Dohme ) Consultancy

Novartis Pharma AG ) Sponsorship of

Schering-Plough Ltd ) Departmental

Boots Healthcare Ltd ) Seminars

AstraZeneca ) Fellowships No

Aventis Pharma )

Cow & Gate Ltd ) Consultancy

Datex-Ohmeda Ltd ) Sponsorship of

Ferring Pharmaceuticals Ltd ) Departmental

Fisher & Paykel Healthcare Ltd ) Seminars

Mead Nutritionals ) Meetings No

Crookes Healthcare ) Sponsorship

Natus Neonatal Ltd )

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l a r

a t i o n o f I n t e r e s t s 125

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Professor T son Nestle UK Ltd ) Meetings

(continued) SMA Nutrition ) Sponsorship

3M Healthcare )

Wyeth Labs )

SHS International Ltd )

Sanofi Synthelabo )

Bristol Myers Squibb )

Dr R None None

Professor N Thomson None AstraZeneca Support for Clinical Yes

Trial

Professor I Weller None Gilead Sciences Co-chair of an Yes

oversight committee

GlaxoKline which is over-seeing Yes

a 5-6 million dollar

Boehinger Ingelheim program of research Yes

on the side effects

Merck of HIV drugs. Yes

This programme is

Roche supported by these Yes

listed companies.

Agouron In additional some Yes

of these companies

Abbott are sponsoring trials Yes

in Professor Weller's

dept. but he is not

Pharmacia Upjohn involved in the studies. No

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

126 C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l

a r a t i o n o f I n t e r e s t s

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Dr P Wilkie Consumer Health Information Consultancy with None

Centre (CHIC). Member of honorarium of £250

the advisory group which per meeting

is indirectly funded by the

member companies of the

Proprietary Association of

Great Britain (PAGB).

Group meets 2-3 times per

year. PAGB organises CHIC.

PAGB trade organisation

for OTC medicines.

CHIC does not know the

member companies.

Dr F None Unilever Research Grant Yes

Procter and Gamble Report Yes

Research Funding Research Grant Yes

Professor K Woodhouse None Aventis ) Clinical Research No

Alaz Corporation ) Trials No

Boehringer Ingleheim ) No

Eisai ) Yes

Eli Lilly ) Yes

Elan ) Yes

MSD ) Yes

Neotherapeutics ) No

Pharmicia/Upjohn ) No

Proctor/Gamble ) Yes

Shire ) No

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l a r

a t i o n o f I n t e r e s t s 127

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Professor K Woodhouse GlaxoKline ) Clinical Research No

(continued) Theramex Corporation ) Research Yes

Toyama ) No

Dr P Amersham Shares None

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

128 C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l

a r a t i o n o f I n t e r e s t s

CHEMISTRY, PHARMACY & STANDARDS SUB-COMMITTEE

MEMBERS HAVE DECLARED CURRENT PERSONAL AND NON-PERSONAL INTERESTS AS

FOLLOWS:

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Professor Pfizer Patent advice consultancy GlaxoKline )

Research Grant Yes

E Aulton Fees paid (Jan to Feb 2002) R P Scherer ) to Department Yes

Pfizer ) Yes

AstraZeneca ) Yes

Professor Graham British Biotech Consultancy AstraZeneca Research

Funding Yes

Buckton Generics UK Consultancy GlaxoKline Research Funding Yes

Eli Lilly Shares/Wife employed by Novartis Research Funding Yes

Company Pfizer Research Funding No

Schering Plough Consultancy Schering Plough Research Funding Yes

Elan Consultancy Norvatis Research funding Yes

Powderject Contract Research Yes

Studies

Norvatis Research Funding Yes

Cenes Research Funding Yes

ICI Research Funding Yes

(not pharmaceutical)

Prof H Calam None None

Dr T Calvert See entry under Committee on Safety of Medicines

Ms Judith A Cantrill None None

Dr J None Merck-Lipha ) Research Funding Yes

Pfizer ) Yes

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l a r

a t i o n o f I n t e r e s t s 129

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Dr J GlaxoKline ) Research Yes

(continued) Pharmacia ) Funding Yes

Convance ) Yes

Uniqema (ICI involved bulk ) Yes

drug and excipient manufacture )

ML Labs ) Yes

Dr Alastair G son None Abbott Labs No

Avecia Ltd No

Celltech Chiroscience No

Faulding Pharm No

Noprvartis Animal Health No

PathoGenesis Corp. No

Quintles, Scotland No

Vericore Ltd No

Cephalon UK No

CP Pharmaceuticals No

Merck & Co Inc. No

Pfizer No

Prometic Biosciences No

SKB No

Speywood Biopharm No

Professor D J G Davies Vectura Ltd Non Excutive Director/

AstraZeneca Yes

Consultant/ Shareholder Biogemma He was, until Sept. 01 Yes

Boots the Dean of the Yes

Britannia Pharmaceuticals Yes

Capsugel Faculty of Yes

Chiesi Farmaceutici Science, University Yes

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

130 C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l

a r a t i o n o f I n t e r e s t s

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Professor D J G Davies DERA of Bath, which has Yes

(continued) Glaxo Wellcome six departments. Yes

The companies listed

Nickerson BIOCHEM provide research Yes

ML grants or contracts to Yes

Miat academic staff within Yes

Novartis one or more of the Yes

Pfizer departments. The Yes

Ranbaxy Dean is not in Yes

Rotta receipt of any Yes

Rhône Poulenc Rorer grants from these Yes

R.P. Scherer DDS Companies, (except Yes

Serono those also listed in Yes

& Nephew the Personal Yes

Sterix Interests column), Yes

Syntex He is merely the Head Yes

Unilever Of the Faculty's Yes

Vanguard Administration Yes

Professor Biotec Laboratories Ltd Directorship, Shares,

Convance Clinicals/ ) Consultancy Yes

P Denyer Grants and Consultancy Reriaproval )

Kodak Ltd Consultancy Eschmann Equipment ) Yes

(lapsed Dec 2001) Superdrug Pharmacy ) Yes

Destiny Pharma Ltd Research sponsorship Colorcon Ltd ) Yes

Oxoid Research Sponsorship Custom Pharmaceuticals ) Training Yes

Unilever Research studentship GlaxoKline ) Yes

(lapsed Jan 2002) Sterilox Medical )

Procter & Gamble Research sponsorship Novo Nordisk ) Research Yes

Samo Research Sponsorship Astra Pharmaceuticals ) Grants Yes

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l a r

a t i o n o f I n t e r e s t s 131

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Professor Reckitt Benkisevr Research Grant Cellective

Sauflow ) Yes

P Denyer (continued) Biocompatibles Research Sponsorship

Pharmaceuticals )

Advanced Biotechnologies Research Sponsorship Abbott Labs ) Yes

JSD Technologies (dormant) Directorship Craig Medical Products ) No

Optometric Technology ) Yes

MSD ) Yes

BOC ) No

Shire Pharmacuticals ) Yes

APS/ Berk Pharmaceuticals Consultancy/ Yes

Training/ Donations

MBM Technology Consultancy/ Research Yes

Pfizer Donation No

Professor Ruth Duncan Pharmacia ) Milestone Payments/ Abbott Labs )

Sponsorship for Yes

Access Pharmaceuticals ) Royalties/ Prizes Access pharmaceuticals )

International Yes

Advanced Polymer systems ) Research Advnced Polymer Systems )

Conference in Yes

Eurand Inter. ) Amgen Inc ) January 2000 Yes

ML Labs ) Support Asta Medica ) Also requested for Yes

Xenova ) Aventis ) January 2002 Yes

Cell Therapeutics Inc ) BASF ) Yes

Daiichi ) Consultancy Bayer ) Yes

Bespak ) Consultancy Boehringer Ingelheim ) Yes

Syngenix ) Pending Cell Therapeutics ) Yes

GlaxoKline ) Yes

Hoffman La Roche ) Yes

Merk KgaA ) Yes

PolyMASC Pharmaceuticals ) Yes

Rhone Poulenc ) Yes

Schering ) Yes

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

132 C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l

a r a t i o n o f I n t e r e s t s

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Professor Ruth Duncan Transgene Inc ) Yes

(continued) Vectura Ltd ) Yes

Yamanouchi ) Yes

Dr Gillian M Eccleston Glaxo Wellcome Consultancy (product) Glaxo

Wellcome Student Grant Yes

Procter and Gamble Consultancy (product) 3M Student Grant Yes

Pfizer Postgraduate Student/ Yes

Post Doctoral Grant

Professor Halation Shares/ Fees Aventis Research

Contract Yes

Marriott MedPharm Shares/ Consultancy Sir Halley Trust

Research Contract Yes

Vectura Ltd Shares/ Consultancy GlaxoKline Research Contract Yes

Remedia Directorship MedPharm Ltd Research Contract Yes

Galephar Consultancy

Controlled Therapeutics Consultancy

Pfizer Consultancy

Aventis Consultancy

Dr A Meredith AstraZeneca Lecture Fees Pfizer Study grant Yes

GlaxoKline Lecture & Consultancy/ Fees

MSD Consultancy

Boehringer Ingelheim Lecture Fees, Consultancy

Pfizer Lecture Fees, Consultancy

Professor Midgley See Entry under the Committee on Safety of

Medicines

(Chairman)

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l a r

a t i o n o f I n t e r e s t s 133

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Prof D Thurston Spirogen Ltd Shares, Director, Grants None

Yan Ji Chemicals Shares, Director, Grants

Yanikem Shares, Director, Grants

Oxford Glyco Sciences Collaboration

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

134 C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l

a r a t i o n o f I n t e r e s t s

BIOLOGICALS SUB-COMMITTEE

MEMBERS HAVE DECLARED CURRENT PERSONAL AND NON-PERSONAL INTERESTS AS

FOLLOWS:

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Professor Gordon Duff See entry under the Committee on Safety of

Medicines

(Chairman)

Professor Calam None None

Dr Moira Bruce None None

Professor Christoper Bucke British Biotech Shares None

GlaxoKline Shares

..

Professor Mark Ferguson Cambridge Antibody Technology Shares Pfizer

Case Studentship Yes

Renova Co-Founder/ CEO/ Shares Renovo Case Studentship Yes

British Biotechnology Shares

Medical Solutions PLC Consultancy

& Nephew Research Grant Yes

Seton Scholl Research Grant Yes

AstraZeneca Research Grant Yes

Dr G F Hill None Baxter Honorarium for No

Organising Scientific

Meeting

Bayer Sponsorship to Attend No

2 Meetings

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l a r

a t i o n o f I n t e r e s t s 135

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Professor Jeffries None GlaxoKline Grant to department

Yes

to cover out of hours

advice to research

virologists

Professor Pedro AstraZeneca Consultancy AstraZeneca Research Grants

Yes

Lowenstein Genopoietic, Paris Scientific Advisory Board

Intronn Plc Scientific Collaboration

Gen Vec Scientific Collaboration

Emeritus Professor Celltech Shares None

Mitchison AstraZeneca Shares

GlaxoKline Shares

Professor North NeuroSearch AS Consultancy AstraZeneca Major

Grants

Sophion Consultancy

Neuromics Board of Directors,

Scientific Advisory Board

Transqeuomic Shares and Advisory Board

Professor S H Ralston Procter & Gamble Consultancy

Lilly Consultancy

Aventis Research Grant

Dr G C Schild None None

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

136 C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l

a r a t i o n o f I n t e r e s t s

PHARMACOVIGILANCE SUB-COMMITTEE

MEMBERS HAVE DECLARED CURRENT PERSONAL AND NON PERSONAL INTERESTS AS

FOLLOWS:

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Professor M Kendall None Menarini ) Dept Research Yes

AstraZeneca ) Grant Yes

Dr K Beard None None

Dr R Ferner Pfizer 1 Free Lunch None

Professor J M Hunt None None

Professor R H GlaxoKline/ ) Consultancy & Norvatis ) No

personal Support Yes

Glaxo Wellcome ) Speaker's Fees ) for two primary care

AstraZeneca ) Wyeth ) organisations – The Yes

Boots P/L Consultancy Fees ) PCSG and the ESPCG

Janssen Cilag ) in which he is involved Yes

Mrs A Lee None None

Dr T M Mac Pharmacia ) Consultancy, honoraria Aventis )

Commissioned Yes

Boehringer Ingelheim ) for Lectures Bristol-Myers Squibb ) Research

Yes

Novartis Trial Coordinator, GSK ) Yes

Consultancy, Honoraria Kotobuki ) Yes

for Lectures Eli Lilly ) Yes

Pfizer USA Consultancy Novartis Healthcare ) Yes

Novartis Healthcare Consultancy Novartis ) Yes

AstraZeneca Honoraria for Lectures Menarini ) Yes

Pfizer ) Yes

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l a r

a t i o n o f I n t e r e s t s 137

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Dr T M Mac Solvay Honoraria for Lectures Pharmacia )

Commissioned Yes

(continued) GSK (GlaxoKline) ) Expired Personal ) Research and

Lundbeck ) Conflicts (1 year ago) ) Research Fellowship

Roche No

MSD No

Wyeth No

Bayer No

Professor K McPherson Leryl, Day & Co Solicitors Consultancy on

action None

re 3rd Generation Oral

Contraceptives

Prof M Pirmohamed None Pfizer ) NPNS – Research Yes

Ask ) Grant Yes

Aventis ) Non Personal Yes

Bristol Myers Squibb ) Research Grant Yes

Merck Sharp and Dohme Ltd ) No

Professor P Routledge Healthcare Education Services Fees for

training of Roche ABPI Funded registrar Yes

Pharmaceutical Industry AstraZeneca ABPI Funded registrar Yes

Staff (Roche) for Dept Pharmacology,

Takeda Europe Research Consultancy Fees UWCM

Dr S H L Pfizer Consultancy Pfizer Research Grant Yes

Lundbeck Consultancy Kotobuici Research Grant No

AstraZeneca Research Grant Yes

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

138 C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l

a r a t i o n o f I n t e r e s t s

CSM/MCA EXTERNAL ADVISORY PANEL

MEMBERS HAVE DECLARED CURRENT PERSONAL AND NON PERSONAL INTERESTS AS

FOLLOWS:

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Dr L R I Baker None None

Dr D N Bateman None Jansssen-Cilag Education Grant for Yes

Research Fellow

Studying ethics of

Clinical Research

(Joint Supervisor).

AstraZeneca The Poisons Bureau Yes

provides Code- (On-going

Breaking service from

for them out of previous

hours years)

Dr J Bingham None Guerbet Departmental study Yes

of Pharmaceutical for

imaging lymph nodos in

head and neck cancer

Serono Departmental study of Yes

contrast for multiple

sclerosis

Prof R Buckley None Bausch/ Lomb Sponsorship of part- Yes

time academic post

at City Uni.

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l a r

a t i o n o f I n t e r e s t s 139

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Prof R D R Camp Novartis UK Consultancy (ongoing) None

re dermatological products

Schering-Plough ) One off paid consultancy

Powderject/ Akos ) in last year (skin related

) products)

Elan Pharmaceuticals One off unpaid consultancy

(favour for a friend)

Dr A J Cant Gilead Sciences Limited Educational Donation Grifols

Educational donation Yes

towards attendance at towards unit attendance

Espid meeting in Lithuania at EBMT meeting,

Aventis Pasteur Merieux Lecture fees Swizerland

MSD Ltd Gilead Sciences Educational donation Yes

towards CGD research

study

Prof I A Choonara None Astra Research Grant Yes

SSL International Advice for Res. Funds Yes

Interlern Advisor Yes

Boots Advice for Res. Funds Yes

Dr T Clutton-Brock None None

Prof S M Cobbe Bristol Myers Squibb Consultancy/ Grant Bristol Myers

Squibb Research Grant Yes

Procter and Gamble Consultancy

AstraZeneca Consultancy/ Lecture Fees

Boehringer Ingelheim Consultancy

Pfizer Consultancy

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

140 C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l

a r a t i o n o f I n t e r e s t s

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Dr J Compston Procter & Gamble Consultancy None

Eli Lilly Consultancy

Servier Consultancy

Norvatis Consultancy

Prof M Contreras None B P L Part of the NBS Yes

(NBS is her employer)

Baxter/Cerus Given advice and firm No

has sponsored the NBS

Haemonetics Given advice and firm No

has sponsored the NBS

Prof R W Cooke None None

Dr G M Boots Shares (67 in total) None

Prof D S Davies AstraZeneca Share Holder Servier R & D ) Commissioned

Yes

Services Labortories Consultancy GSK ) Research Yes

ML Labs Non-Exec Director AstraZeneca ) Yes

& Shareholder OSI Pharmaceuticals ) Yes

MSD ) Yes

Schering Healthcare ) Yes

Bristol Myers Squibb ) Yes

Mrs C Dealey None & Nephew Medical Commission for Yes

research work

Dr G B Drummond None AstraZeneca Project Overheads Yes

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l a r

a t i o n o f I n t e r e s t s 141

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Professor E Elias AstraZeneca Consultancy None

Norgine Consultancy/ Grant

Dr R Ferner Pfizer 1 Free Lunch None

Prof J lyn None None

Prof E Gale None None

Dr T Gibson None None

Dr A Glasier Leiras Consultancy – Reproductive Organon Grant No

medicine Schering Sponsorship Meeting Yes

GSK Shares

Dr C Grattan Schering Plough £800 for visiting Guest Schering Plough

Local Organiser allergy Yes

Lecture Fee, Copnehagen symposium March 2002

10/01 Ppt. Dernatology (£4000 sponsorship for

Meeting meeting expenses,

including Honorarium

for visiting speakers,

travel & accommodation

Prof C E M Griffiths Novartis Consultancy (Dermatology Novartis

Pharma ) Research Yes

Products) Agennix ) Grants Yes

Galderma ) Fujisawa ) Yes

Biogen ) Stiefel ) Yes

Centocor ) Consultancy Unilever ) Yes

Wyeth-Ayerst )

Stiefel )

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

142 C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l

a r a t i o n o f I n t e r e s t s

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Prof K Gull RBM (Italy) Consultancy None

Dr D Heaf None None

Dr P Hindmarsh GSK £400 consultancy on None

growth

Prof P D Home Novo Nordisk ) Consultancy Novo Nordisk ) Research

Grants / Yes

GSK ) GSK ) Projectsupport Yes

Aventis Pharma ) Aventis ) Yes

Pfizer Inc ) Pfizer ) Yes

Merck Inc )

Prof P Houghton Oxford Natural Products PLC Consultancy Higher

Nature Ltd Research Grant to No

Ancile Pharmaceuticals Consultancy Dept of Pharmacy

Beehealth Ltd Consultancy Stiefel Labs Research Grant to Yes

Dept of Pharmacy

Kinetique Research Grant to Yes

Dept of Pharmacy

Dr J Ironside Merck, USA Consultancy (for 1 day None

meeting)

Prof P Issacson None None

Prof D A Isenberg Celltech Consultancy – 80% donated Celltech )

Trial of an TRF and Yes

to arthritis research, 20% Knoll ) monodoral anitbody – Yes

he keeps for himself. ) pays for part-time

) research fellowship

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l a r

a t i o n o f I n t e r e s t s 143

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Prof D A Isenberg Hoechst n Roussel Paid for him to attend

(continued) the American College of

Rheumotology DFM in

San Francisco (Nov 2001)

Dr S B Kayne Labolife SA Spain Personal non-specific None

consultancy

Boots Company Personal training

consultancy

Dr C R Kennedy GSK Travel cost contribution Jansen-Cilag ) Grant

towards Yes

GSK ) salary

Norvatis Meeting expenses

Prof B J Kirby None None

Miss G Lachelin AstraZeneca Shares None

Prof I Lauder None AstraZeneca Research Project Yes

funding in our

Institution

Dr R J A Logan AstraZeneca Shares ( & Consultancy AstraZeneca Grants

Yes

as from Feb 2002)

GSK Shares

Merck Consultancy as from

Dec 2001

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

144 C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l

a r a t i o n o f I n t e r e s t s

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Prof R MacSween Kline Beecham Shares None

Medeva Share

Proteus Shares

Prof J O'D McGee Hoffman La Roche Consultancy None

Merck Shares

Pfizer Shares

SmitrhKline Beecham Shares

Prof I Mc Janssen Cilag Anti-dementia Consultancy/ Fees Janssen

Cilag Research Grant Yes

drugs Pfizer/ Eisai Research Grant Yes

Shire Pharmaceuticals Anti- Fees

dementia drugs

Novartis Anti-dementia drugs Fees

Pfizer Anti-dementia drugs Fees

Eisai Anti-dementia drugs Fees

Lilly Pharmaceuticals Anti- Fees

psychotics

Prof J McKillop None None

Dr E None North American Vaccine Grant to study Yes

(now Baxter Healthcare) meningococcal C

Wyeth Lederle Vaccines ) Grant to support post- Yes

Chiron Biocine ) licensure surveillance Yes

Baxter Health Care ) of meningococcal C Yes

) conjugate vaccine

Kline Beecham Grant to study Yes

meningococcal C

and HIB in infants

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l a r

a t i o n o f I n t e r e s t s 145

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Dr E Aventis Pasteur CMI testing in Yes

(continued) adolescent sera

Dr H Mitchison None None

Dr C Moss None Dermal Labs Sponsored Annual Yes

Dinner and

sponsorship

of educational

activities and

patient support

work

Crookes Health Care ) Sponsorship Recurrent

UCB Pharma ) of Educational Recurrent

Dermapharm ) activities and Recurrent

Dumex ) patient support Recurrent

Galderma ) work Recurrent

Nutragena ) Recurrent

Leo ) Recurrent

Quinoderm ) Recurrent

SSL International ) Recurrent

Stiefel Labortories ) Recurrent

Fujisawa Clinical Trial/ Fees Yes

Dr B R O'Driscoll AstraZeneca No Finiancial Interst, None

but they sponsored my

attendance at European

Respiratory Society

meeting in Berlin in

Sept 2001

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

146 C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l

a r a t i o n o f I n t e r e s t s

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Dr R J Pinney None None

Dr S A Qureshi Numed Inc, Hopkinton USA Royalty payments None

(Balloon Catheter)

Professor P Routledge Healthcare Education Services Fees for

training of Roche ABPI Funded registrar Yes

Pharmaceutical Industry

Staff (Roche)

Takeda Europe Research Consultancy Fees AstraZeneca ABPI Funded

registrar Yes

for Dept Pharmacology,

UWCM

Dr L Rylah None None

Prof R Seymour Pfizer Consultancy Reckitt Benkiser Grant No

AstraZeneca Grant Yes

Oraldent Grant Yes

Prof P J Shaw Amgen Principal Investigator None

Aventis Research Grant

Dr R Shearer None None

Prof S Shovron VCB Honorarium for Lecturing None

and travel expenses

and Advisoray board

membership

Dr P C C None None

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l a r

a t i o n o f I n t e r e s t s 147

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Prof S K Metris Therapeutics Director/ Shares/ Fees None

Schering Consultancy

Pfizer Consultancy

Dr N Soni Portex Limited Consultancy Nexstar Grant Yes

Pharmacia Consultancy National Blood Service Grant Yes

Novo Seron Consultancy

Prof S G Spiro Lilly Industries Grant to " London Lung None

Cancer Group " to fund

a national trust

Dr M s Chugai Pharma Received Travel grant to Chugai Pharma

Chairman of Yes

support cost of attendance International Clinical

at a scientific meeting Trial which receives

(£1000 in 2001) Grant support towards

data management costs

(Paid via the United

Kingdom Children's

Cancer Study Group)

Prof R D Sturrock Amgen Consultancy Amgen ) Commission Yes

Centocor ) for Research Yes

Roche ) Work No

Genmab ) Yes

Serono ) Yes

Dr P B Sullivan Nutricia Ltd Research Grant Yes

Norgine Ltd Research Grant Yes

SHS Ltd Travel Grant No

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

148 C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l

a r a t i o n o f I n t e r e s t s

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Dr R Tasker None Meed ston Ltd Travel Grant No

Dr R Thorpe None Amgen Grant (Contract) No

Prof G T Tucker Napp Consultancy GSK Res Student/ Research Yes

GSK Consumer Products Consultancy Consortium

Yamanochic Consultancy GSK Consumer Products Grant Yes

AstraZeneca Consultancy Pfizer Research Consortium Yes

Charnwood Consultancy AstraZeneca Research Consortium Yes

ML Labs Consultancy Norvatis Research Consortium Yes

Boots Healthcare Consultancy Synthelabo Research Consortium Yes

Pfizer Consultancy Cyprolex Research Consortium Yes

Teva Fees Novo Nordisk A/S Research Consortium Yes

Roche Fees

Dr M Tucker AstraZeneca Pension None

Mr A Tullo None Chauvin Payments per patients Yes

studied to Endowments

fund used principally for

Travel Grants for Junior

medical colleagues

AstraZeneca Collaborative work with Yes

Christie Hospital tending

to payments per patient

studied to Endowments

fund for purchases of

equipment for Eye Hospital.

MD travel grants for medical

and non medical staff to mtgs.

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l a r

a t i o n o f I n t e r e s t s 149

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Prof J C E Underwood Merck Consultancy (2001) Novartis Head of

department Yes

Medical Solutions Advisory Board/ Member in which a collegue

has support from

Novartis

Dr J H Walter None None

Prof D Warrell None None

Dr D C Wheeler Wyeth Pharmaceuticals Honoraria Amgen (UK)

Sponsorship of Yes

Novartis Honoraria a student

Amgen UK Ltd Fee Paid Work Genzyme Commission for No

Genzyme Consultancy research work

Bristol Myers Squibb Honararia Merck Sharpe & Dohme ) Support of

clinical Yes

Merck Sharpe & Dohme Honararia Schering Plough ) Trial Yes

Ortho Biotech Honararia

Prof G T Aphton Corporation Consultancy None

Prof N A None Byk Gulden Consultant on Yes

Educational

Programme

Posted November 5, 2004 · November 5, 2004

COMMITTEE ON SAFETY OF MEDICINES

http://www.mca.gov.uk/aboutagency/regframework/csm/csmhome.htm

MEMBERS HAVE DECLARED CURRENT PERSONAL AND NON-PERSONAL INTERESTS AS

FOLLOWS:

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Dr M Armitage None None

Professor D Ashby None Pfiers Statistical Talks No

Professor T R E Eli-Lilly Fees Sanofi-Synthelabo Grant Yes

CeNeS Consultancy

Pfizer Consultancy

Novartis Consultancy (clozapine)

Ms H Barnett None None

Professor A Blenkinsopp & -MS D Consultancy Servier )

Departmental Yes

Pfizer ) Research Yes

GSK ) Funding Yes

MSD ) Yes

Professor A Breckenridge None None

(Chairman)

Professor J Caldwell AstraZeneca Consultancy None

Schering-Plough Consultancy

Boots Healthcare Fees

Norton Healthcare Consultancy

Huntingdon Life Sciences Director

Pharmacia Consultancy

Amedis pharmaceuticals Director/Shareholder

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

120 C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l

a r a t i o n o f I n t e r e s t s

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Dr R Calvert None None

Dr T Chambers None None

Professor J Chipman Sci.Lucent McGhan Ltd Consultancy AstraZeneca )

Research Yes

GlaxoKline ) Grants Yes

Inamed Consultancy Syngenta Research Collaboration Yes

Professor J Darbyshire Genomyc Advisory Board Member Bristol-Myers

Squibb ) Support for Clinical Yes

GlaxoKline ) Trials eg. Salaries, Yes

Janssen Research Foundation ) running expenses, Yes

SLA Pharma, Osmetech ) consultancy, drugs, Yes

Roche ) reduced price pumps Yes

Merck ) and assays Yes

Unimed Pharmaceuticals US ) Yes

Eurpoean Society for ) Yes

Oncological & Immunological )

Research ) Yes

Gilead Sciences ) Yes

Pierre Fabre ) Yes

Pharmacia/Upjohn ) Yes

Chugai-Rhone-Poulenc ) Yes

Schering Plough ) Yes

Sanofi ) Yes

Aventis ) Yes

Wyeth & Wyeth-Ayerst ) Yes

Baxter ) Yes

Fresenius ) Yes

ML Labs ) Yes

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l a r

a t i o n o f I n t e r e s t s 121

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Professor J Darbyshire Interneuron ) Support for Clinical Yes

(continued) DuPont Pharma & Merck ) Trials eg. Salaries, Yes

Boehringer Ingelheim ) running expenses, Yes

Agouron ) consultancy, drugs, Yes

Virco ) reduced price pumps Yes

Chiron ) and assays Yes

Antisoma ) Yes

Lilly ) Yes

Intermune DSMC, Stiefel ) Yes

DSMC ) Yes

BMS Pharmacovigilance ) Yes

Professor H Dargie Servier Consultancy Merk AG Research Grant No

GlaxoKline Consultancy Novartis Research Grant Yes

Rhone-Poulenc Rorer Consultancy MSD Research Grant Yes

Chugai Consultancy Mitsubishi Research Grant Yes

Pharmacia Research Grant Yes

Meatronic Research Grant Yes

Dr M Donaghy Octapharma Honorarium for lecturing None

21 May 2001

GlaxoKline Shareholder

Professor G Duff Interleukin Genetics Inc, Scientific Advisory Board

Interleukin Genetics Inc Renewal of Yes

Boston (diagnostics Member and shares research contract

company) with Sheffield Uni.

Medical Solutions Plc, Scientific Advisory Board Shares to Sheffield

Uni.

Oxford (Mainly cancer Member and shares

diagnostics company) Stock Holding

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

122 C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l

a r a t i o n o f I n t e r e s t s

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Professor G Duff British Biotechnology Shares GlaxoKline New

Research Yes

(continued) Molecular Skincare Ltd, Shares/Director Contract with

Sheffield (Uni. of Sheffield spin- Sheffield Uni.

out company in skin research)

Dr B GlaxoKline Shares Galen Research Grant Yes

Boots Shares

Pharmacia Upjohn Fees

Professor S Eykyn None None

Dr J C Forfar GlaxoKline Shares Novartis Lecture to General No

Amersham Intl Shares Practitioners

Professor E Gordon- Bayer Plc Consultancy Chugai Research

Grants No

Toyama Europe Ltd Consultancy Amgen Research Grants No

Eli Lilly Consultancy Pfizer Research Grants No

Professor M Kendall None Menarini Dept Research Grant Yes

AstraZeneca Dept Research Grant Yes

Professor M Langman None Merck Sharpe Dohme Research support/ Yes

Consultancy

Norvartis Consultancy Yes

AstraZeneca Research Support Yes

Dr A V P Mackay None Laxendale Ltd Research Funding Lapsed

Support for a approx

consultant 1 year

colleague ago

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l a r

a t i o n o f I n t e r e s t s 123

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Professor H McGavock None None

Professor J Midgley Amylin Europe Limited ) Consultancy None

Mitsubishi Chemical (UK) )

Oxford Glycosciences )

Baxter SA )

FERX Inc )

Mallinckrodt Inc. )

Inex Pharm Corp )

Lonza Group )

Prof D Nutt GSK Consultancy/ Shareholding UCB Grant Yes

Janssen ) Consultancy GSK Grant Yes

Servier ) Wyeth Grant Yes

Esteve ) Pierre Fabre Grant Yes

Lundbeck ) Lundbeck Grant Yes

MSD )

AstraZeneca )

Wyeth ) Honoraria

Pierre Fabre )

Organon )

Professor B Park None Pfizer ) Advice Yes

Syngenta ) Yes

Glaxo Wellcome ) Yes

Professor J Petrie None None

(Co-Vice Chair)

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

124 C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l

a r a t i o n o f I n t e r e s t s

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

PDr J H Scarffe None None

Professor J F Smyth ISIS Pharmaceuticals Consultancy Novartis )

Clinical Trials Yes

Antigenics Consultancy Boehinger Mannheim ) Yes

Enchira Consultancy/ Shares British Biotech ) No

GlaxoKline Consultancy Eisai ) No

Pharma Mar Shares/ Consultancy Roche ) No

QLT Consultancy Knoll ) No

Abbott Consultancy AstraZeneca Fellowship Yes

Centocor – Non personal Clinical Trial Yes

specific

Professor T son Intercern Ltd Consultancy Abbott

Laboratories ) Fellowships

.. & Hanburys Ltd ) Meeting

Astra Respiratory ) Sponsorship

GlaxoKline ) University Yes

Merck Sharp Dohme ) Consultancy

Novartis Pharma AG ) Sponsorship of

Schering-Plough Ltd ) Departmental

Boots Healthcare Ltd ) Seminars

AstraZeneca ) Fellowships No

Aventis Pharma )

Cow & Gate Ltd ) Consultancy

Datex-Ohmeda Ltd ) Sponsorship of

Ferring Pharmaceuticals Ltd ) Departmental

Fisher & Paykel Healthcare Ltd ) Seminars

Mead Nutritionals ) Meetings No

Crookes Healthcare ) Sponsorship

Natus Neonatal Ltd )

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l a r

a t i o n o f I n t e r e s t s 125

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Professor T son Nestle UK Ltd ) Meetings

(continued) SMA Nutrition ) Sponsorship

3M Healthcare )

Wyeth Labs )

SHS International Ltd )

Sanofi Synthelabo )

Bristol Myers Squibb )

Dr R None None

Professor N Thomson None AstraZeneca Support for Clinical Yes

Trial

Professor I Weller None Gilead Sciences Co-chair of an Yes

oversight committee

GlaxoKline which is over-seeing Yes

a 5-6 million dollar

Boehinger Ingelheim program of research Yes

on the side effects

Merck of HIV drugs. Yes

This programme is

Roche supported by these Yes

listed companies.

Agouron In additional some Yes

of these companies

Abbott are sponsoring trials Yes

in Professor Weller's

dept. but he is not

Pharmacia Upjohn involved in the studies. No

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

126 C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l

a r a t i o n o f I n t e r e s t s

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Dr P Wilkie Consumer Health Information Consultancy with None

Centre (CHIC). Member of honorarium of £250

the advisory group which per meeting

is indirectly funded by the

member companies of the

Proprietary Association of

Great Britain (PAGB).

Group meets 2-3 times per

year. PAGB organises CHIC.

PAGB trade organisation

for OTC medicines.

CHIC does not know the

member companies.

Dr F None Unilever Research Grant Yes

Procter and Gamble Report Yes

Research Funding Research Grant Yes

Professor K Woodhouse None Aventis ) Clinical Research No

Alaz Corporation ) Trials No

Boehringer Ingleheim ) No

Eisai ) Yes

Eli Lilly ) Yes

Elan ) Yes

MSD ) Yes

Neotherapeutics ) No

Pharmicia/Upjohn ) No

Proctor/Gamble ) Yes

Shire ) No

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l a r

a t i o n o f I n t e r e s t s 127

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Professor K Woodhouse GlaxoKline ) Clinical Research No

(continued) Theramex Corporation ) Research Yes

Toyama ) No

Dr P Amersham Shares None

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

128 C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l

a r a t i o n o f I n t e r e s t s

CHEMISTRY, PHARMACY & STANDARDS SUB-COMMITTEE

MEMBERS HAVE DECLARED CURRENT PERSONAL AND NON-PERSONAL INTERESTS AS

FOLLOWS:

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Professor Pfizer Patent advice consultancy GlaxoKline )

Research Grant Yes

E Aulton Fees paid (Jan to Feb 2002) R P Scherer ) to Department Yes

Pfizer ) Yes

AstraZeneca ) Yes

Professor Graham British Biotech Consultancy AstraZeneca Research

Funding Yes

Buckton Generics UK Consultancy GlaxoKline Research Funding Yes

Eli Lilly Shares/Wife employed by Novartis Research Funding Yes

Company Pfizer Research Funding No

Schering Plough Consultancy Schering Plough Research Funding Yes

Elan Consultancy Norvatis Research funding Yes

Powderject Contract Research Yes

Studies

Norvatis Research Funding Yes

Cenes Research Funding Yes

ICI Research Funding Yes

(not pharmaceutical)

Prof H Calam None None

Dr T Calvert See entry under Committee on Safety of Medicines

Ms Judith A Cantrill None None

Dr J None Merck-Lipha ) Research Funding Yes

Pfizer ) Yes

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l a r

a t i o n o f I n t e r e s t s 129

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Dr J GlaxoKline ) Research Yes

(continued) Pharmacia ) Funding Yes

Convance ) Yes

Uniqema (ICI involved bulk ) Yes

drug and excipient manufacture )

ML Labs ) Yes

Dr Alastair G son None Abbott Labs No

Avecia Ltd No

Celltech Chiroscience No

Faulding Pharm No

Noprvartis Animal Health No

PathoGenesis Corp. No

Quintles, Scotland No

Vericore Ltd No

Cephalon UK No

CP Pharmaceuticals No

Merck & Co Inc. No

Pfizer No

Prometic Biosciences No

SKB No

Speywood Biopharm No

Professor D J G Davies Vectura Ltd Non Excutive Director/

AstraZeneca Yes

Consultant/ Shareholder Biogemma He was, until Sept. 01 Yes

Boots the Dean of the Yes

Britannia Pharmaceuticals Yes

Capsugel Faculty of Yes

Chiesi Farmaceutici Science, University Yes

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

130 C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l

a r a t i o n o f I n t e r e s t s

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Professor D J G Davies DERA of Bath, which has Yes

(continued) Glaxo Wellcome six departments. Yes

The companies listed

Nickerson BIOCHEM provide research Yes

ML grants or contracts to Yes

Miat academic staff within Yes

Novartis one or more of the Yes

Pfizer departments. The Yes

Ranbaxy Dean is not in Yes

Rotta receipt of any Yes

Rhône Poulenc Rorer grants from these Yes

R.P. Scherer DDS Companies, (except Yes

Serono those also listed in Yes

& Nephew the Personal Yes

Sterix Interests column), Yes

Syntex He is merely the Head Yes

Unilever Of the Faculty's Yes

Vanguard Administration Yes

Professor Biotec Laboratories Ltd Directorship, Shares,

Convance Clinicals/ ) Consultancy Yes

P Denyer Grants and Consultancy Reriaproval )

Kodak Ltd Consultancy Eschmann Equipment ) Yes

(lapsed Dec 2001) Superdrug Pharmacy ) Yes

Destiny Pharma Ltd Research sponsorship Colorcon Ltd ) Yes

Oxoid Research Sponsorship Custom Pharmaceuticals ) Training Yes

Unilever Research studentship GlaxoKline ) Yes

(lapsed Jan 2002) Sterilox Medical )

Procter & Gamble Research sponsorship Novo Nordisk ) Research Yes

Samo Research Sponsorship Astra Pharmaceuticals ) Grants Yes

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l a r

a t i o n o f I n t e r e s t s 131

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Professor Reckitt Benkisevr Research Grant Cellective

Sauflow ) Yes

P Denyer (continued) Biocompatibles Research Sponsorship

Pharmaceuticals )

Advanced Biotechnologies Research Sponsorship Abbott Labs ) Yes

JSD Technologies (dormant) Directorship Craig Medical Products ) No

Optometric Technology ) Yes

MSD ) Yes

BOC ) No

Shire Pharmacuticals ) Yes

APS/ Berk Pharmaceuticals Consultancy/ Yes

Training/ Donations

MBM Technology Consultancy/ Research Yes

Pfizer Donation No

Professor Ruth Duncan Pharmacia ) Milestone Payments/ Abbott Labs )

Sponsorship for Yes

Access Pharmaceuticals ) Royalties/ Prizes Access pharmaceuticals )

International Yes

Advanced Polymer systems ) Research Advnced Polymer Systems )

Conference in Yes

Eurand Inter. ) Amgen Inc ) January 2000 Yes

ML Labs ) Support Asta Medica ) Also requested for Yes

Xenova ) Aventis ) January 2002 Yes

Cell Therapeutics Inc ) BASF ) Yes

Daiichi ) Consultancy Bayer ) Yes

Bespak ) Consultancy Boehringer Ingelheim ) Yes

Syngenix ) Pending Cell Therapeutics ) Yes

GlaxoKline ) Yes

Hoffman La Roche ) Yes

Merk KgaA ) Yes

PolyMASC Pharmaceuticals ) Yes

Rhone Poulenc ) Yes

Schering ) Yes

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

132 C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l

a r a t i o n o f I n t e r e s t s

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Professor Ruth Duncan Transgene Inc ) Yes

(continued) Vectura Ltd ) Yes

Yamanouchi ) Yes

Dr Gillian M Eccleston Glaxo Wellcome Consultancy (product) Glaxo

Wellcome Student Grant Yes

Procter and Gamble Consultancy (product) 3M Student Grant Yes

Pfizer Postgraduate Student/ Yes

Post Doctoral Grant

Professor Halation Shares/ Fees Aventis Research

Contract Yes

Marriott MedPharm Shares/ Consultancy Sir Halley Trust

Research Contract Yes

Vectura Ltd Shares/ Consultancy GlaxoKline Research Contract Yes

Remedia Directorship MedPharm Ltd Research Contract Yes

Galephar Consultancy

Controlled Therapeutics Consultancy

Pfizer Consultancy

Aventis Consultancy

Dr A Meredith AstraZeneca Lecture Fees Pfizer Study grant Yes

GlaxoKline Lecture & Consultancy/ Fees

MSD Consultancy

Boehringer Ingelheim Lecture Fees, Consultancy

Pfizer Lecture Fees, Consultancy

Professor Midgley See Entry under the Committee on Safety of

Medicines

(Chairman)

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l a r

a t i o n o f I n t e r e s t s 133

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Prof D Thurston Spirogen Ltd Shares, Director, Grants None

Yan Ji Chemicals Shares, Director, Grants

Yanikem Shares, Director, Grants

Oxford Glyco Sciences Collaboration

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

134 C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l

a r a t i o n o f I n t e r e s t s

BIOLOGICALS SUB-COMMITTEE

MEMBERS HAVE DECLARED CURRENT PERSONAL AND NON-PERSONAL INTERESTS AS

FOLLOWS:

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Professor Gordon Duff See entry under the Committee on Safety of

Medicines

(Chairman)

Professor Calam None None

Dr Moira Bruce None None

Professor Christoper Bucke British Biotech Shares None

GlaxoKline Shares

..

Professor Mark Ferguson Cambridge Antibody Technology Shares Pfizer

Case Studentship Yes

Renova Co-Founder/ CEO/ Shares Renovo Case Studentship Yes

British Biotechnology Shares

Medical Solutions PLC Consultancy

& Nephew Research Grant Yes

Seton Scholl Research Grant Yes

AstraZeneca Research Grant Yes

Dr G F Hill None Baxter Honorarium for No

Organising Scientific

Meeting

Bayer Sponsorship to Attend No

2 Meetings

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l a r

a t i o n o f I n t e r e s t s 135

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Professor Jeffries None GlaxoKline Grant to department

Yes

to cover out of hours

advice to research

virologists

Professor Pedro AstraZeneca Consultancy AstraZeneca Research Grants

Yes

Lowenstein Genopoietic, Paris Scientific Advisory Board

Intronn Plc Scientific Collaboration

Gen Vec Scientific Collaboration

Emeritus Professor Celltech Shares None

Mitchison AstraZeneca Shares

GlaxoKline Shares

Professor North NeuroSearch AS Consultancy AstraZeneca Major

Grants

Sophion Consultancy

Neuromics Board of Directors,

Scientific Advisory Board

Transqeuomic Shares and Advisory Board

Professor S H Ralston Procter & Gamble Consultancy

Lilly Consultancy

Aventis Research Grant

Dr G C Schild None None

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

136 C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l

a r a t i o n o f I n t e r e s t s

PHARMACOVIGILANCE SUB-COMMITTEE

MEMBERS HAVE DECLARED CURRENT PERSONAL AND NON PERSONAL INTERESTS AS

FOLLOWS:

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Professor M Kendall None Menarini ) Dept Research Yes

AstraZeneca ) Grant Yes

Dr K Beard None None

Dr R Ferner Pfizer 1 Free Lunch None

Professor J M Hunt None None

Professor R H GlaxoKline/ ) Consultancy & Norvatis ) No

personal Support Yes

Glaxo Wellcome ) Speaker's Fees ) for two primary care

AstraZeneca ) Wyeth ) organisations – The Yes

Boots P/L Consultancy Fees ) PCSG and the ESPCG

Janssen Cilag ) in which he is involved Yes

Mrs A Lee None None

Dr T M Mac Pharmacia ) Consultancy, honoraria Aventis )

Commissioned Yes

Boehringer Ingelheim ) for Lectures Bristol-Myers Squibb ) Research

Yes

Novartis Trial Coordinator, GSK ) Yes

Consultancy, Honoraria Kotobuki ) Yes

for Lectures Eli Lilly ) Yes

Pfizer USA Consultancy Novartis Healthcare ) Yes

Novartis Healthcare Consultancy Novartis ) Yes

AstraZeneca Honoraria for Lectures Menarini ) Yes

Pfizer ) Yes

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l a r

a t i o n o f I n t e r e s t s 137

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Dr T M Mac Solvay Honoraria for Lectures Pharmacia )

Commissioned Yes

(continued) GSK (GlaxoKline) ) Expired Personal ) Research and

Lundbeck ) Conflicts (1 year ago) ) Research Fellowship

Roche No

MSD No

Wyeth No

Bayer No

Professor K McPherson Leryl, Day & Co Solicitors Consultancy on

action None

re 3rd Generation Oral

Contraceptives

Prof M Pirmohamed None Pfizer ) NPNS – Research Yes

Ask ) Grant Yes

Aventis ) Non Personal Yes

Bristol Myers Squibb ) Research Grant Yes

Merck Sharp and Dohme Ltd ) No

Professor P Routledge Healthcare Education Services Fees for

training of Roche ABPI Funded registrar Yes

Pharmaceutical Industry AstraZeneca ABPI Funded registrar Yes

Staff (Roche) for Dept Pharmacology,

Takeda Europe Research Consultancy Fees UWCM

Dr S H L Pfizer Consultancy Pfizer Research Grant Yes

Lundbeck Consultancy Kotobuici Research Grant No

AstraZeneca Research Grant Yes

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

138 C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l

a r a t i o n o f I n t e r e s t s

CSM/MCA EXTERNAL ADVISORY PANEL

MEMBERS HAVE DECLARED CURRENT PERSONAL AND NON PERSONAL INTERESTS AS

FOLLOWS:

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Dr L R I Baker None None

Dr D N Bateman None Jansssen-Cilag Education Grant for Yes

Research Fellow

Studying ethics of

Clinical Research

(Joint Supervisor).

AstraZeneca The Poisons Bureau Yes

provides Code- (On-going

Breaking service from

for them out of previous

hours years)

Dr J Bingham None Guerbet Departmental study Yes

of Pharmaceutical for

imaging lymph nodos in

head and neck cancer

Serono Departmental study of Yes

contrast for multiple

sclerosis

Prof R Buckley None Bausch/ Lomb Sponsorship of part- Yes

time academic post

at City Uni.

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l a r

a t i o n o f I n t e r e s t s 139

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Prof R D R Camp Novartis UK Consultancy (ongoing) None

re dermatological products

Schering-Plough ) One off paid consultancy

Powderject/ Akos ) in last year (skin related

) products)

Elan Pharmaceuticals One off unpaid consultancy

(favour for a friend)

Dr A J Cant Gilead Sciences Limited Educational Donation Grifols

Educational donation Yes

towards attendance at towards unit attendance

Espid meeting in Lithuania at EBMT meeting,

Aventis Pasteur Merieux Lecture fees Swizerland

MSD Ltd Gilead Sciences Educational donation Yes

towards CGD research

study

Prof I A Choonara None Astra Research Grant Yes

SSL International Advice for Res. Funds Yes

Interlern Advisor Yes

Boots Advice for Res. Funds Yes

Dr T Clutton-Brock None None

Prof S M Cobbe Bristol Myers Squibb Consultancy/ Grant Bristol Myers

Squibb Research Grant Yes

Procter and Gamble Consultancy

AstraZeneca Consultancy/ Lecture Fees

Boehringer Ingelheim Consultancy

Pfizer Consultancy

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

140 C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l

a r a t i o n o f I n t e r e s t s

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Dr J Compston Procter & Gamble Consultancy None

Eli Lilly Consultancy

Servier Consultancy

Norvatis Consultancy

Prof M Contreras None B P L Part of the NBS Yes

(NBS is her employer)

Baxter/Cerus Given advice and firm No

has sponsored the NBS

Haemonetics Given advice and firm No

has sponsored the NBS

Prof R W Cooke None None

Dr G M Boots Shares (67 in total) None

Prof D S Davies AstraZeneca Share Holder Servier R & D ) Commissioned

Yes

Services Labortories Consultancy GSK ) Research Yes

ML Labs Non-Exec Director AstraZeneca ) Yes

& Shareholder OSI Pharmaceuticals ) Yes

MSD ) Yes

Schering Healthcare ) Yes

Bristol Myers Squibb ) Yes

Mrs C Dealey None & Nephew Medical Commission for Yes

research work

Dr G B Drummond None AstraZeneca Project Overheads Yes

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l a r

a t i o n o f I n t e r e s t s 141

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Professor E Elias AstraZeneca Consultancy None

Norgine Consultancy/ Grant

Dr R Ferner Pfizer 1 Free Lunch None

Prof J lyn None None

Prof E Gale None None

Dr T Gibson None None

Dr A Glasier Leiras Consultancy – Reproductive Organon Grant No

medicine Schering Sponsorship Meeting Yes

GSK Shares

Dr C Grattan Schering Plough £800 for visiting Guest Schering Plough

Local Organiser allergy Yes

Lecture Fee, Copnehagen symposium March 2002

10/01 Ppt. Dernatology (£4000 sponsorship for

Meeting meeting expenses,

including Honorarium

for visiting speakers,

travel & accommodation

Prof C E M Griffiths Novartis Consultancy (Dermatology Novartis

Pharma ) Research Yes

Products) Agennix ) Grants Yes

Galderma ) Fujisawa ) Yes

Biogen ) Stiefel ) Yes

Centocor ) Consultancy Unilever ) Yes

Wyeth-Ayerst )

Stiefel )

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

142 C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l

a r a t i o n o f I n t e r e s t s

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Prof K Gull RBM (Italy) Consultancy None

Dr D Heaf None None

Dr P Hindmarsh GSK £400 consultancy on None

growth

Prof P D Home Novo Nordisk ) Consultancy Novo Nordisk ) Research

Grants / Yes

GSK ) GSK ) Projectsupport Yes

Aventis Pharma ) Aventis ) Yes

Pfizer Inc ) Pfizer ) Yes

Merck Inc )

Prof P Houghton Oxford Natural Products PLC Consultancy Higher

Nature Ltd Research Grant to No

Ancile Pharmaceuticals Consultancy Dept of Pharmacy

Beehealth Ltd Consultancy Stiefel Labs Research Grant to Yes

Dept of Pharmacy

Kinetique Research Grant to Yes

Dept of Pharmacy

Dr J Ironside Merck, USA Consultancy (for 1 day None

meeting)

Prof P Issacson None None

Prof D A Isenberg Celltech Consultancy – 80% donated Celltech )

Trial of an TRF and Yes

to arthritis research, 20% Knoll ) monodoral anitbody – Yes

he keeps for himself. ) pays for part-time

) research fellowship

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l a r

a t i o n o f I n t e r e s t s 143

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Prof D A Isenberg Hoechst n Roussel Paid for him to attend

(continued) the American College of

Rheumotology DFM in

San Francisco (Nov 2001)

Dr S B Kayne Labolife SA Spain Personal non-specific None

consultancy

Boots Company Personal training

consultancy

Dr C R Kennedy GSK Travel cost contribution Jansen-Cilag ) Grant

towards Yes

GSK ) salary

Norvatis Meeting expenses

Prof B J Kirby None None

Miss G Lachelin AstraZeneca Shares None

Prof I Lauder None AstraZeneca Research Project Yes

funding in our

Institution

Dr R J A Logan AstraZeneca Shares ( & Consultancy AstraZeneca Grants

Yes

as from Feb 2002)

GSK Shares

Merck Consultancy as from

Dec 2001

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

144 C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l

a r a t i o n o f I n t e r e s t s

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Prof R MacSween Kline Beecham Shares None

Medeva Share

Proteus Shares

Prof J O'D McGee Hoffman La Roche Consultancy None

Merck Shares

Pfizer Shares

SmitrhKline Beecham Shares

Prof I Mc Janssen Cilag Anti-dementia Consultancy/ Fees Janssen

Cilag Research Grant Yes

drugs Pfizer/ Eisai Research Grant Yes

Shire Pharmaceuticals Anti- Fees

dementia drugs

Novartis Anti-dementia drugs Fees

Pfizer Anti-dementia drugs Fees

Eisai Anti-dementia drugs Fees

Lilly Pharmaceuticals Anti- Fees

psychotics

Prof J McKillop None None

Dr E None North American Vaccine Grant to study Yes

(now Baxter Healthcare) meningococcal C

Wyeth Lederle Vaccines ) Grant to support post- Yes

Chiron Biocine ) licensure surveillance Yes

Baxter Health Care ) of meningococcal C Yes

) conjugate vaccine

Kline Beecham Grant to study Yes

meningococcal C

and HIB in infants

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l a r

a t i o n o f I n t e r e s t s 145

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Dr E Aventis Pasteur CMI testing in Yes

(continued) adolescent sera

Dr H Mitchison None None

Dr C Moss None Dermal Labs Sponsored Annual Yes

Dinner and

sponsorship

of educational

activities and

patient support

work

Crookes Health Care ) Sponsorship Recurrent

UCB Pharma ) of Educational Recurrent

Dermapharm ) activities and Recurrent

Dumex ) patient support Recurrent

Galderma ) work Recurrent

Nutragena ) Recurrent

Leo ) Recurrent

Quinoderm ) Recurrent

SSL International ) Recurrent

Stiefel Labortories ) Recurrent

Fujisawa Clinical Trial/ Fees Yes

Dr B R O'Driscoll AstraZeneca No Finiancial Interst, None

but they sponsored my

attendance at European

Respiratory Society

meeting in Berlin in

Sept 2001

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

146 C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l

a r a t i o n o f I n t e r e s t s

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Dr R J Pinney None None

Dr S A Qureshi Numed Inc, Hopkinton USA Royalty payments None

(Balloon Catheter)

Professor P Routledge Healthcare Education Services Fees for

training of Roche ABPI Funded registrar Yes

Pharmaceutical Industry

Staff (Roche)

Takeda Europe Research Consultancy Fees AstraZeneca ABPI Funded

registrar Yes

for Dept Pharmacology,

UWCM

Dr L Rylah None None

Prof R Seymour Pfizer Consultancy Reckitt Benkiser Grant No

AstraZeneca Grant Yes

Oraldent Grant Yes

Prof P J Shaw Amgen Principal Investigator None

Aventis Research Grant

Dr R Shearer None None

Prof S Shovron VCB Honorarium for Lecturing None

and travel expenses

and Advisoray board

membership

Dr P C C None None

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l a r

a t i o n o f I n t e r e s t s 147

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Prof S K Metris Therapeutics Director/ Shares/ Fees None

Schering Consultancy

Pfizer Consultancy

Dr N Soni Portex Limited Consultancy Nexstar Grant Yes

Pharmacia Consultancy National Blood Service Grant Yes

Novo Seron Consultancy

Prof S G Spiro Lilly Industries Grant to " London Lung None

Cancer Group " to fund

a national trust

Dr M s Chugai Pharma Received Travel grant to Chugai Pharma

Chairman of Yes

support cost of attendance International Clinical

at a scientific meeting Trial which receives

(£1000 in 2001) Grant support towards

data management costs

(Paid via the United

Kingdom Children's

Cancer Study Group)

Prof R D Sturrock Amgen Consultancy Amgen ) Commission Yes

Centocor ) for Research Yes

Roche ) Work No

Genmab ) Yes

Serono ) Yes

Dr P B Sullivan Nutricia Ltd Research Grant Yes

Norgine Ltd Research Grant Yes

SHS Ltd Travel Grant No

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

148 C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l

a r a t i o n o f I n t e r e s t s

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Dr R Tasker None Meed ston Ltd Travel Grant No

Dr R Thorpe None Amgen Grant (Contract) No

Prof G T Tucker Napp Consultancy GSK Res Student/ Research Yes

GSK Consumer Products Consultancy Consortium

Yamanochic Consultancy GSK Consumer Products Grant Yes

AstraZeneca Consultancy Pfizer Research Consortium Yes

Charnwood Consultancy AstraZeneca Research Consortium Yes

ML Labs Consultancy Norvatis Research Consortium Yes

Boots Healthcare Consultancy Synthelabo Research Consortium Yes

Pfizer Consultancy Cyprolex Research Consortium Yes

Teva Fees Novo Nordisk A/S Research Consortium Yes

Roche Fees

Dr M Tucker AstraZeneca Pension None

Mr A Tullo None Chauvin Payments per patients Yes

studied to Endowments

fund used principally for

Travel Grants for Junior

medical colleagues

AstraZeneca Collaborative work with Yes

Christie Hospital tending

to payments per patient

studied to Endowments

fund for purchases of

equipment for Eye Hospital.

MD travel grants for medical

and non medical staff to mtgs.

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l a r

a t i o n o f I n t e r e s t s 149

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Prof J C E Underwood Merck Consultancy (2001) Novartis Head of

department Yes

Medical Solutions Advisory Board/ Member in which a collegue

has support from

Novartis

Dr J H Walter None None

Prof D Warrell None None

Dr D C Wheeler Wyeth Pharmaceuticals Honoraria Amgen (UK)

Sponsorship of Yes

Novartis Honoraria a student

Amgen UK Ltd Fee Paid Work Genzyme Commission for No

Genzyme Consultancy research work

Bristol Myers Squibb Honararia Merck Sharpe & Dohme ) Support of

clinical Yes

Merck Sharpe & Dohme Honararia Schering Plough ) Trial Yes

Ortho Biotech Honararia

Prof G T Aphton Corporation Consultancy None

Prof N A None Byk Gulden Consultant on Yes

Educational

Programme

Posted November 5, 2004 · November 5, 2004

COMMITTEE ON SAFETY OF MEDICINES

http://www.mca.gov.uk/aboutagency/regframework/csm/csmhome.htm

MEMBERS HAVE DECLARED CURRENT PERSONAL AND NON-PERSONAL INTERESTS AS

FOLLOWS:

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Dr M Armitage None None

Professor D Ashby None Pfiers Statistical Talks No

Professor T R E Eli-Lilly Fees Sanofi-Synthelabo Grant Yes

CeNeS Consultancy

Pfizer Consultancy

Novartis Consultancy (clozapine)

Ms H Barnett None None

Professor A Blenkinsopp & -MS D Consultancy Servier )

Departmental Yes

Pfizer ) Research Yes

GSK ) Funding Yes

MSD ) Yes

Professor A Breckenridge None None

(Chairman)

Professor J Caldwell AstraZeneca Consultancy None

Schering-Plough Consultancy

Boots Healthcare Fees

Norton Healthcare Consultancy

Huntingdon Life Sciences Director

Pharmacia Consultancy

Amedis pharmaceuticals Director/Shareholder

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

120 C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l

a r a t i o n o f I n t e r e s t s

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Dr R Calvert None None

Dr T Chambers None None

Professor J Chipman Sci.Lucent McGhan Ltd Consultancy AstraZeneca )

Research Yes

GlaxoKline ) Grants Yes

Inamed Consultancy Syngenta Research Collaboration Yes

Professor J Darbyshire Genomyc Advisory Board Member Bristol-Myers

Squibb ) Support for Clinical Yes

GlaxoKline ) Trials eg. Salaries, Yes

Janssen Research Foundation ) running expenses, Yes

SLA Pharma, Osmetech ) consultancy, drugs, Yes

Roche ) reduced price pumps Yes

Merck ) and assays Yes

Unimed Pharmaceuticals US ) Yes

Eurpoean Society for ) Yes

Oncological & Immunological )

Research ) Yes

Gilead Sciences ) Yes

Pierre Fabre ) Yes

Pharmacia/Upjohn ) Yes

Chugai-Rhone-Poulenc ) Yes

Schering Plough ) Yes

Sanofi ) Yes

Aventis ) Yes

Wyeth & Wyeth-Ayerst ) Yes

Baxter ) Yes

Fresenius ) Yes

ML Labs ) Yes

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l a r

a t i o n o f I n t e r e s t s 121

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Professor J Darbyshire Interneuron ) Support for Clinical Yes

(continued) DuPont Pharma & Merck ) Trials eg. Salaries, Yes

Boehringer Ingelheim ) running expenses, Yes

Agouron ) consultancy, drugs, Yes

Virco ) reduced price pumps Yes

Chiron ) and assays Yes

Antisoma ) Yes

Lilly ) Yes

Intermune DSMC, Stiefel ) Yes

DSMC ) Yes

BMS Pharmacovigilance ) Yes

Professor H Dargie Servier Consultancy Merk AG Research Grant No

GlaxoKline Consultancy Novartis Research Grant Yes

Rhone-Poulenc Rorer Consultancy MSD Research Grant Yes

Chugai Consultancy Mitsubishi Research Grant Yes

Pharmacia Research Grant Yes

Meatronic Research Grant Yes

Dr M Donaghy Octapharma Honorarium for lecturing None

21 May 2001

GlaxoKline Shareholder

Professor G Duff Interleukin Genetics Inc, Scientific Advisory Board

Interleukin Genetics Inc Renewal of Yes

Boston (diagnostics Member and shares research contract

company) with Sheffield Uni.

Medical Solutions Plc, Scientific Advisory Board Shares to Sheffield

Uni.

Oxford (Mainly cancer Member and shares

diagnostics company) Stock Holding

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

122 C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l

a r a t i o n o f I n t e r e s t s

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Professor G Duff British Biotechnology Shares GlaxoKline New

Research Yes

(continued) Molecular Skincare Ltd, Shares/Director Contract with

Sheffield (Uni. of Sheffield spin- Sheffield Uni.

out company in skin research)

Dr B GlaxoKline Shares Galen Research Grant Yes

Boots Shares

Pharmacia Upjohn Fees

Professor S Eykyn None None

Dr J C Forfar GlaxoKline Shares Novartis Lecture to General No

Amersham Intl Shares Practitioners

Professor E Gordon- Bayer Plc Consultancy Chugai Research

Grants No

Toyama Europe Ltd Consultancy Amgen Research Grants No

Eli Lilly Consultancy Pfizer Research Grants No

Professor M Kendall None Menarini Dept Research Grant Yes

AstraZeneca Dept Research Grant Yes

Professor M Langman None Merck Sharpe Dohme Research support/ Yes

Consultancy

Norvartis Consultancy Yes

AstraZeneca Research Support Yes

Dr A V P Mackay None Laxendale Ltd Research Funding Lapsed

Support for a approx

consultant 1 year

colleague ago

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l a r

a t i o n o f I n t e r e s t s 123

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Professor H McGavock None None

Professor J Midgley Amylin Europe Limited ) Consultancy None

Mitsubishi Chemical (UK) )

Oxford Glycosciences )

Baxter SA )

FERX Inc )

Mallinckrodt Inc. )

Inex Pharm Corp )

Lonza Group )

Prof D Nutt GSK Consultancy/ Shareholding UCB Grant Yes

Janssen ) Consultancy GSK Grant Yes

Servier ) Wyeth Grant Yes

Esteve ) Pierre Fabre Grant Yes

Lundbeck ) Lundbeck Grant Yes

MSD )

AstraZeneca )

Wyeth ) Honoraria

Pierre Fabre )

Organon )

Professor B Park None Pfizer ) Advice Yes

Syngenta ) Yes

Glaxo Wellcome ) Yes

Professor J Petrie None None

(Co-Vice Chair)

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

124 C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l

a r a t i o n o f I n t e r e s t s

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

PDr J H Scarffe None None

Professor J F Smyth ISIS Pharmaceuticals Consultancy Novartis )

Clinical Trials Yes

Antigenics Consultancy Boehinger Mannheim ) Yes

Enchira Consultancy/ Shares British Biotech ) No

GlaxoKline Consultancy Eisai ) No

Pharma Mar Shares/ Consultancy Roche ) No

QLT Consultancy Knoll ) No

Abbott Consultancy AstraZeneca Fellowship Yes

Centocor – Non personal Clinical Trial Yes

specific

Professor T son Intercern Ltd Consultancy Abbott

Laboratories ) Fellowships

.. & Hanburys Ltd ) Meeting

Astra Respiratory ) Sponsorship

GlaxoKline ) University Yes

Merck Sharp Dohme ) Consultancy

Novartis Pharma AG ) Sponsorship of

Schering-Plough Ltd ) Departmental

Boots Healthcare Ltd ) Seminars

AstraZeneca ) Fellowships No

Aventis Pharma )

Cow & Gate Ltd ) Consultancy

Datex-Ohmeda Ltd ) Sponsorship of

Ferring Pharmaceuticals Ltd ) Departmental

Fisher & Paykel Healthcare Ltd ) Seminars

Mead Nutritionals ) Meetings No

Crookes Healthcare ) Sponsorship

Natus Neonatal Ltd )

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l a r

a t i o n o f I n t e r e s t s 125

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Professor T son Nestle UK Ltd ) Meetings

(continued) SMA Nutrition ) Sponsorship

3M Healthcare )

Wyeth Labs )

SHS International Ltd )

Sanofi Synthelabo )

Bristol Myers Squibb )

Dr R None None

Professor N Thomson None AstraZeneca Support for Clinical Yes

Trial

Professor I Weller None Gilead Sciences Co-chair of an Yes

oversight committee

GlaxoKline which is over-seeing Yes

a 5-6 million dollar

Boehinger Ingelheim program of research Yes

on the side effects

Merck of HIV drugs. Yes

This programme is

Roche supported by these Yes

listed companies.

Agouron In additional some Yes

of these companies

Abbott are sponsoring trials Yes

in Professor Weller's

dept. but he is not

Pharmacia Upjohn involved in the studies. No

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

126 C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l

a r a t i o n o f I n t e r e s t s

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Dr P Wilkie Consumer Health Information Consultancy with None

Centre (CHIC). Member of honorarium of £250

the advisory group which per meeting

is indirectly funded by the

member companies of the

Proprietary Association of

Great Britain (PAGB).

Group meets 2-3 times per

year. PAGB organises CHIC.

PAGB trade organisation

for OTC medicines.

CHIC does not know the

member companies.

Dr F None Unilever Research Grant Yes

Procter and Gamble Report Yes

Research Funding Research Grant Yes

Professor K Woodhouse None Aventis ) Clinical Research No

Alaz Corporation ) Trials No

Boehringer Ingleheim ) No

Eisai ) Yes

Eli Lilly ) Yes

Elan ) Yes

MSD ) Yes

Neotherapeutics ) No

Pharmicia/Upjohn ) No

Proctor/Gamble ) Yes

Shire ) No

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l a r

a t i o n o f I n t e r e s t s 127

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Professor K Woodhouse GlaxoKline ) Clinical Research No

(continued) Theramex Corporation ) Research Yes

Toyama ) No

Dr P Amersham Shares None

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

128 C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l

a r a t i o n o f I n t e r e s t s

CHEMISTRY, PHARMACY & STANDARDS SUB-COMMITTEE

MEMBERS HAVE DECLARED CURRENT PERSONAL AND NON-PERSONAL INTERESTS AS

FOLLOWS:

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Professor Pfizer Patent advice consultancy GlaxoKline )

Research Grant Yes

E Aulton Fees paid (Jan to Feb 2002) R P Scherer ) to Department Yes

Pfizer ) Yes

AstraZeneca ) Yes

Professor Graham British Biotech Consultancy AstraZeneca Research

Funding Yes

Buckton Generics UK Consultancy GlaxoKline Research Funding Yes

Eli Lilly Shares/Wife employed by Novartis Research Funding Yes

Company Pfizer Research Funding No

Schering Plough Consultancy Schering Plough Research Funding Yes

Elan Consultancy Norvatis Research funding Yes

Powderject Contract Research Yes

Studies

Norvatis Research Funding Yes

Cenes Research Funding Yes

ICI Research Funding Yes

(not pharmaceutical)

Prof H Calam None None

Dr T Calvert See entry under Committee on Safety of Medicines

Ms Judith A Cantrill None None

Dr J None Merck-Lipha ) Research Funding Yes

Pfizer ) Yes

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l a r

a t i o n o f I n t e r e s t s 129

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Dr J GlaxoKline ) Research Yes

(continued) Pharmacia ) Funding Yes

Convance ) Yes

Uniqema (ICI involved bulk ) Yes

drug and excipient manufacture )

ML Labs ) Yes

Dr Alastair G son None Abbott Labs No

Avecia Ltd No

Celltech Chiroscience No

Faulding Pharm No

Noprvartis Animal Health No

PathoGenesis Corp. No

Quintles, Scotland No

Vericore Ltd No

Cephalon UK No

CP Pharmaceuticals No

Merck & Co Inc. No

Pfizer No

Prometic Biosciences No

SKB No

Speywood Biopharm No

Professor D J G Davies Vectura Ltd Non Excutive Director/

AstraZeneca Yes

Consultant/ Shareholder Biogemma He was, until Sept. 01 Yes

Boots the Dean of the Yes

Britannia Pharmaceuticals Yes

Capsugel Faculty of Yes

Chiesi Farmaceutici Science, University Yes

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

130 C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l

a r a t i o n o f I n t e r e s t s

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Professor D J G Davies DERA of Bath, which has Yes

(continued) Glaxo Wellcome six departments. Yes

The companies listed

Nickerson BIOCHEM provide research Yes

ML grants or contracts to Yes

Miat academic staff within Yes

Novartis one or more of the Yes

Pfizer departments. The Yes

Ranbaxy Dean is not in Yes

Rotta receipt of any Yes

Rhône Poulenc Rorer grants from these Yes

R.P. Scherer DDS Companies, (except Yes

Serono those also listed in Yes

& Nephew the Personal Yes

Sterix Interests column), Yes

Syntex He is merely the Head Yes

Unilever Of the Faculty's Yes

Vanguard Administration Yes

Professor Biotec Laboratories Ltd Directorship, Shares,

Convance Clinicals/ ) Consultancy Yes

P Denyer Grants and Consultancy Reriaproval )

Kodak Ltd Consultancy Eschmann Equipment ) Yes

(lapsed Dec 2001) Superdrug Pharmacy ) Yes

Destiny Pharma Ltd Research sponsorship Colorcon Ltd ) Yes

Oxoid Research Sponsorship Custom Pharmaceuticals ) Training Yes

Unilever Research studentship GlaxoKline ) Yes

(lapsed Jan 2002) Sterilox Medical )

Procter & Gamble Research sponsorship Novo Nordisk ) Research Yes

Samo Research Sponsorship Astra Pharmaceuticals ) Grants Yes

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l a r

a t i o n o f I n t e r e s t s 131

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Professor Reckitt Benkisevr Research Grant Cellective

Sauflow ) Yes

P Denyer (continued) Biocompatibles Research Sponsorship

Pharmaceuticals )

Advanced Biotechnologies Research Sponsorship Abbott Labs ) Yes

JSD Technologies (dormant) Directorship Craig Medical Products ) No

Optometric Technology ) Yes

MSD ) Yes

BOC ) No

Shire Pharmacuticals ) Yes

APS/ Berk Pharmaceuticals Consultancy/ Yes

Training/ Donations

MBM Technology Consultancy/ Research Yes

Pfizer Donation No

Professor Ruth Duncan Pharmacia ) Milestone Payments/ Abbott Labs )

Sponsorship for Yes

Access Pharmaceuticals ) Royalties/ Prizes Access pharmaceuticals )

International Yes

Advanced Polymer systems ) Research Advnced Polymer Systems )

Conference in Yes

Eurand Inter. ) Amgen Inc ) January 2000 Yes

ML Labs ) Support Asta Medica ) Also requested for Yes

Xenova ) Aventis ) January 2002 Yes

Cell Therapeutics Inc ) BASF ) Yes

Daiichi ) Consultancy Bayer ) Yes

Bespak ) Consultancy Boehringer Ingelheim ) Yes

Syngenix ) Pending Cell Therapeutics ) Yes

GlaxoKline ) Yes

Hoffman La Roche ) Yes

Merk KgaA ) Yes

PolyMASC Pharmaceuticals ) Yes

Rhone Poulenc ) Yes

Schering ) Yes

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

132 C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l

a r a t i o n o f I n t e r e s t s

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Professor Ruth Duncan Transgene Inc ) Yes

(continued) Vectura Ltd ) Yes

Yamanouchi ) Yes

Dr Gillian M Eccleston Glaxo Wellcome Consultancy (product) Glaxo

Wellcome Student Grant Yes

Procter and Gamble Consultancy (product) 3M Student Grant Yes

Pfizer Postgraduate Student/ Yes

Post Doctoral Grant

Professor Halation Shares/ Fees Aventis Research

Contract Yes

Marriott MedPharm Shares/ Consultancy Sir Halley Trust

Research Contract Yes

Vectura Ltd Shares/ Consultancy GlaxoKline Research Contract Yes

Remedia Directorship MedPharm Ltd Research Contract Yes

Galephar Consultancy

Controlled Therapeutics Consultancy

Pfizer Consultancy

Aventis Consultancy

Dr A Meredith AstraZeneca Lecture Fees Pfizer Study grant Yes

GlaxoKline Lecture & Consultancy/ Fees

MSD Consultancy

Boehringer Ingelheim Lecture Fees, Consultancy

Pfizer Lecture Fees, Consultancy

Professor Midgley See Entry under the Committee on Safety of

Medicines

(Chairman)

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l a r

a t i o n o f I n t e r e s t s 133

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Prof D Thurston Spirogen Ltd Shares, Director, Grants None

Yan Ji Chemicals Shares, Director, Grants

Yanikem Shares, Director, Grants

Oxford Glyco Sciences Collaboration

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

134 C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l

a r a t i o n o f I n t e r e s t s

BIOLOGICALS SUB-COMMITTEE

MEMBERS HAVE DECLARED CURRENT PERSONAL AND NON-PERSONAL INTERESTS AS

FOLLOWS:

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Professor Gordon Duff See entry under the Committee on Safety of

Medicines

(Chairman)

Professor Calam None None

Dr Moira Bruce None None

Professor Christoper Bucke British Biotech Shares None

GlaxoKline Shares

..

Professor Mark Ferguson Cambridge Antibody Technology Shares Pfizer

Case Studentship Yes

Renova Co-Founder/ CEO/ Shares Renovo Case Studentship Yes

British Biotechnology Shares

Medical Solutions PLC Consultancy

& Nephew Research Grant Yes

Seton Scholl Research Grant Yes

AstraZeneca Research Grant Yes

Dr G F Hill None Baxter Honorarium for No

Organising Scientific

Meeting

Bayer Sponsorship to Attend No

2 Meetings

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l a r

a t i o n o f I n t e r e s t s 135

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Professor Jeffries None GlaxoKline Grant to department

Yes

to cover out of hours

advice to research

virologists

Professor Pedro AstraZeneca Consultancy AstraZeneca Research Grants

Yes

Lowenstein Genopoietic, Paris Scientific Advisory Board

Intronn Plc Scientific Collaboration

Gen Vec Scientific Collaboration

Emeritus Professor Celltech Shares None

Mitchison AstraZeneca Shares

GlaxoKline Shares

Professor North NeuroSearch AS Consultancy AstraZeneca Major

Grants

Sophion Consultancy

Neuromics Board of Directors,

Scientific Advisory Board

Transqeuomic Shares and Advisory Board

Professor S H Ralston Procter & Gamble Consultancy

Lilly Consultancy

Aventis Research Grant

Dr G C Schild None None

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

136 C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l

a r a t i o n o f I n t e r e s t s

PHARMACOVIGILANCE SUB-COMMITTEE

MEMBERS HAVE DECLARED CURRENT PERSONAL AND NON PERSONAL INTERESTS AS

FOLLOWS:

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Professor M Kendall None Menarini ) Dept Research Yes

AstraZeneca ) Grant Yes

Dr K Beard None None

Dr R Ferner Pfizer 1 Free Lunch None

Professor J M Hunt None None

Professor R H GlaxoKline/ ) Consultancy & Norvatis ) No

personal Support Yes

Glaxo Wellcome ) Speaker's Fees ) for two primary care

AstraZeneca ) Wyeth ) organisations – The Yes

Boots P/L Consultancy Fees ) PCSG and the ESPCG

Janssen Cilag ) in which he is involved Yes

Mrs A Lee None None

Dr T M Mac Pharmacia ) Consultancy, honoraria Aventis )

Commissioned Yes

Boehringer Ingelheim ) for Lectures Bristol-Myers Squibb ) Research

Yes

Novartis Trial Coordinator, GSK ) Yes

Consultancy, Honoraria Kotobuki ) Yes

for Lectures Eli Lilly ) Yes

Pfizer USA Consultancy Novartis Healthcare ) Yes

Novartis Healthcare Consultancy Novartis ) Yes

AstraZeneca Honoraria for Lectures Menarini ) Yes

Pfizer ) Yes

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l a r

a t i o n o f I n t e r e s t s 137

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Dr T M Mac Solvay Honoraria for Lectures Pharmacia )

Commissioned Yes

(continued) GSK (GlaxoKline) ) Expired Personal ) Research and

Lundbeck ) Conflicts (1 year ago) ) Research Fellowship

Roche No

MSD No

Wyeth No

Bayer No

Professor K McPherson Leryl, Day & Co Solicitors Consultancy on

action None

re 3rd Generation Oral

Contraceptives

Prof M Pirmohamed None Pfizer ) NPNS – Research Yes

Ask ) Grant Yes

Aventis ) Non Personal Yes

Bristol Myers Squibb ) Research Grant Yes

Merck Sharp and Dohme Ltd ) No

Professor P Routledge Healthcare Education Services Fees for

training of Roche ABPI Funded registrar Yes

Pharmaceutical Industry AstraZeneca ABPI Funded registrar Yes

Staff (Roche) for Dept Pharmacology,

Takeda Europe Research Consultancy Fees UWCM

Dr S H L Pfizer Consultancy Pfizer Research Grant Yes

Lundbeck Consultancy Kotobuici Research Grant No

AstraZeneca Research Grant Yes

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

138 C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l

a r a t i o n o f I n t e r e s t s

CSM/MCA EXTERNAL ADVISORY PANEL

MEMBERS HAVE DECLARED CURRENT PERSONAL AND NON PERSONAL INTERESTS AS

FOLLOWS:

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Dr L R I Baker None None

Dr D N Bateman None Jansssen-Cilag Education Grant for Yes

Research Fellow

Studying ethics of

Clinical Research

(Joint Supervisor).

AstraZeneca The Poisons Bureau Yes

provides Code- (On-going

Breaking service from

for them out of previous

hours years)

Dr J Bingham None Guerbet Departmental study Yes

of Pharmaceutical for

imaging lymph nodos in

head and neck cancer

Serono Departmental study of Yes

contrast for multiple

sclerosis

Prof R Buckley None Bausch/ Lomb Sponsorship of part- Yes

time academic post

at City Uni.

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l a r

a t i o n o f I n t e r e s t s 139

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Prof R D R Camp Novartis UK Consultancy (ongoing) None

re dermatological products

Schering-Plough ) One off paid consultancy

Powderject/ Akos ) in last year (skin related

) products)

Elan Pharmaceuticals One off unpaid consultancy

(favour for a friend)

Dr A J Cant Gilead Sciences Limited Educational Donation Grifols

Educational donation Yes

towards attendance at towards unit attendance

Espid meeting in Lithuania at EBMT meeting,

Aventis Pasteur Merieux Lecture fees Swizerland

MSD Ltd Gilead Sciences Educational donation Yes

towards CGD research

study

Prof I A Choonara None Astra Research Grant Yes

SSL International Advice for Res. Funds Yes

Interlern Advisor Yes

Boots Advice for Res. Funds Yes

Dr T Clutton-Brock None None

Prof S M Cobbe Bristol Myers Squibb Consultancy/ Grant Bristol Myers

Squibb Research Grant Yes

Procter and Gamble Consultancy

AstraZeneca Consultancy/ Lecture Fees

Boehringer Ingelheim Consultancy

Pfizer Consultancy

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

140 C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l

a r a t i o n o f I n t e r e s t s

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Dr J Compston Procter & Gamble Consultancy None

Eli Lilly Consultancy

Servier Consultancy

Norvatis Consultancy

Prof M Contreras None B P L Part of the NBS Yes

(NBS is her employer)

Baxter/Cerus Given advice and firm No

has sponsored the NBS

Haemonetics Given advice and firm No

has sponsored the NBS

Prof R W Cooke None None

Dr G M Boots Shares (67 in total) None

Prof D S Davies AstraZeneca Share Holder Servier R & D ) Commissioned

Yes

Services Labortories Consultancy GSK ) Research Yes

ML Labs Non-Exec Director AstraZeneca ) Yes

& Shareholder OSI Pharmaceuticals ) Yes

MSD ) Yes

Schering Healthcare ) Yes

Bristol Myers Squibb ) Yes

Mrs C Dealey None & Nephew Medical Commission for Yes

research work

Dr G B Drummond None AstraZeneca Project Overheads Yes

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l a r

a t i o n o f I n t e r e s t s 141

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Professor E Elias AstraZeneca Consultancy None

Norgine Consultancy/ Grant

Dr R Ferner Pfizer 1 Free Lunch None

Prof J lyn None None

Prof E Gale None None

Dr T Gibson None None

Dr A Glasier Leiras Consultancy – Reproductive Organon Grant No

medicine Schering Sponsorship Meeting Yes

GSK Shares

Dr C Grattan Schering Plough £800 for visiting Guest Schering Plough

Local Organiser allergy Yes

Lecture Fee, Copnehagen symposium March 2002

10/01 Ppt. Dernatology (£4000 sponsorship for

Meeting meeting expenses,

including Honorarium

for visiting speakers,

travel & accommodation

Prof C E M Griffiths Novartis Consultancy (Dermatology Novartis

Pharma ) Research Yes

Products) Agennix ) Grants Yes

Galderma ) Fujisawa ) Yes

Biogen ) Stiefel ) Yes

Centocor ) Consultancy Unilever ) Yes

Wyeth-Ayerst )

Stiefel )

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

142 C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l

a r a t i o n o f I n t e r e s t s

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Prof K Gull RBM (Italy) Consultancy None

Dr D Heaf None None

Dr P Hindmarsh GSK £400 consultancy on None

growth

Prof P D Home Novo Nordisk ) Consultancy Novo Nordisk ) Research

Grants / Yes

GSK ) GSK ) Projectsupport Yes

Aventis Pharma ) Aventis ) Yes

Pfizer Inc ) Pfizer ) Yes

Merck Inc )

Prof P Houghton Oxford Natural Products PLC Consultancy Higher

Nature Ltd Research Grant to No

Ancile Pharmaceuticals Consultancy Dept of Pharmacy

Beehealth Ltd Consultancy Stiefel Labs Research Grant to Yes

Dept of Pharmacy

Kinetique Research Grant to Yes

Dept of Pharmacy

Dr J Ironside Merck, USA Consultancy (for 1 day None

meeting)

Prof P Issacson None None

Prof D A Isenberg Celltech Consultancy – 80% donated Celltech )

Trial of an TRF and Yes

to arthritis research, 20% Knoll ) monodoral anitbody – Yes

he keeps for himself. ) pays for part-time

) research fellowship

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l a r

a t i o n o f I n t e r e s t s 143

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Prof D A Isenberg Hoechst n Roussel Paid for him to attend

(continued) the American College of

Rheumotology DFM in

San Francisco (Nov 2001)

Dr S B Kayne Labolife SA Spain Personal non-specific None

consultancy

Boots Company Personal training

consultancy

Dr C R Kennedy GSK Travel cost contribution Jansen-Cilag ) Grant

towards Yes

GSK ) salary

Norvatis Meeting expenses

Prof B J Kirby None None

Miss G Lachelin AstraZeneca Shares None

Prof I Lauder None AstraZeneca Research Project Yes

funding in our

Institution

Dr R J A Logan AstraZeneca Shares ( & Consultancy AstraZeneca Grants

Yes

as from Feb 2002)

GSK Shares

Merck Consultancy as from

Dec 2001

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

144 C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l

a r a t i o n o f I n t e r e s t s

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Prof R MacSween Kline Beecham Shares None

Medeva Share

Proteus Shares

Prof J O'D McGee Hoffman La Roche Consultancy None

Merck Shares

Pfizer Shares

SmitrhKline Beecham Shares

Prof I Mc Janssen Cilag Anti-dementia Consultancy/ Fees Janssen

Cilag Research Grant Yes

drugs Pfizer/ Eisai Research Grant Yes

Shire Pharmaceuticals Anti- Fees

dementia drugs

Novartis Anti-dementia drugs Fees

Pfizer Anti-dementia drugs Fees

Eisai Anti-dementia drugs Fees

Lilly Pharmaceuticals Anti- Fees

psychotics

Prof J McKillop None None

Dr E None North American Vaccine Grant to study Yes

(now Baxter Healthcare) meningococcal C

Wyeth Lederle Vaccines ) Grant to support post- Yes

Chiron Biocine ) licensure surveillance Yes

Baxter Health Care ) of meningococcal C Yes

) conjugate vaccine

Kline Beecham Grant to study Yes

meningococcal C

and HIB in infants

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l a r

a t i o n o f I n t e r e s t s 145

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Dr E Aventis Pasteur CMI testing in Yes

(continued) adolescent sera

Dr H Mitchison None None

Dr C Moss None Dermal Labs Sponsored Annual Yes

Dinner and

sponsorship

of educational

activities and

patient support

work

Crookes Health Care ) Sponsorship Recurrent

UCB Pharma ) of Educational Recurrent

Dermapharm ) activities and Recurrent

Dumex ) patient support Recurrent

Galderma ) work Recurrent

Nutragena ) Recurrent

Leo ) Recurrent

Quinoderm ) Recurrent

SSL International ) Recurrent

Stiefel Labortories ) Recurrent

Fujisawa Clinical Trial/ Fees Yes

Dr B R O'Driscoll AstraZeneca No Finiancial Interst, None

but they sponsored my

attendance at European

Respiratory Society

meeting in Berlin in

Sept 2001

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

146 C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l

a r a t i o n o f I n t e r e s t s

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Dr R J Pinney None None

Dr S A Qureshi Numed Inc, Hopkinton USA Royalty payments None

(Balloon Catheter)

Professor P Routledge Healthcare Education Services Fees for

training of Roche ABPI Funded registrar Yes

Pharmaceutical Industry

Staff (Roche)

Takeda Europe Research Consultancy Fees AstraZeneca ABPI Funded

registrar Yes

for Dept Pharmacology,

UWCM

Dr L Rylah None None

Prof R Seymour Pfizer Consultancy Reckitt Benkiser Grant No

AstraZeneca Grant Yes

Oraldent Grant Yes

Prof P J Shaw Amgen Principal Investigator None

Aventis Research Grant

Dr R Shearer None None

Prof S Shovron VCB Honorarium for Lecturing None

and travel expenses

and Advisoray board

membership

Dr P C C None None

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l a r

a t i o n o f I n t e r e s t s 147

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Prof S K Metris Therapeutics Director/ Shares/ Fees None

Schering Consultancy

Pfizer Consultancy

Dr N Soni Portex Limited Consultancy Nexstar Grant Yes

Pharmacia Consultancy National Blood Service Grant Yes

Novo Seron Consultancy

Prof S G Spiro Lilly Industries Grant to " London Lung None

Cancer Group " to fund

a national trust

Dr M s Chugai Pharma Received Travel grant to Chugai Pharma

Chairman of Yes

support cost of attendance International Clinical

at a scientific meeting Trial which receives

(£1000 in 2001) Grant support towards

data management costs

(Paid via the United

Kingdom Children's

Cancer Study Group)

Prof R D Sturrock Amgen Consultancy Amgen ) Commission Yes

Centocor ) for Research Yes

Roche ) Work No

Genmab ) Yes

Serono ) Yes

Dr P B Sullivan Nutricia Ltd Research Grant Yes

Norgine Ltd Research Grant Yes

SHS Ltd Travel Grant No

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

148 C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l

a r a t i o n o f I n t e r e s t s

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Dr R Tasker None Meed ston Ltd Travel Grant No

Dr R Thorpe None Amgen Grant (Contract) No

Prof G T Tucker Napp Consultancy GSK Res Student/ Research Yes

GSK Consumer Products Consultancy Consortium

Yamanochic Consultancy GSK Consumer Products Grant Yes

AstraZeneca Consultancy Pfizer Research Consortium Yes

Charnwood Consultancy AstraZeneca Research Consortium Yes

ML Labs Consultancy Norvatis Research Consortium Yes

Boots Healthcare Consultancy Synthelabo Research Consortium Yes

Pfizer Consultancy Cyprolex Research Consortium Yes

Teva Fees Novo Nordisk A/S Research Consortium Yes

Roche Fees

Dr M Tucker AstraZeneca Pension None

Mr A Tullo None Chauvin Payments per patients Yes

studied to Endowments

fund used principally for

Travel Grants for Junior

medical colleagues

AstraZeneca Collaborative work with Yes

Christie Hospital tending

to payments per patient

studied to Endowments

fund for purchases of

equipment for Eye Hospital.

MD travel grants for medical

and non medical staff to mtgs.

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l a r

a t i o n o f I n t e r e s t s 149

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Prof J C E Underwood Merck Consultancy (2001) Novartis Head of

department Yes

Medical Solutions Advisory Board/ Member in which a collegue

has support from

Novartis

Dr J H Walter None None

Prof D Warrell None None

Dr D C Wheeler Wyeth Pharmaceuticals Honoraria Amgen (UK)

Sponsorship of Yes

Novartis Honoraria a student

Amgen UK Ltd Fee Paid Work Genzyme Commission for No

Genzyme Consultancy research work

Bristol Myers Squibb Honararia Merck Sharpe & Dohme ) Support of

clinical Yes

Merck Sharpe & Dohme Honararia Schering Plough ) Trial Yes

Ortho Biotech Honararia

Prof G T Aphton Corporation Consultancy None

Prof N A None Byk Gulden Consultant on Yes

Educational

Programme

Posted November 5, 2004 · November 5, 2004

COMMITTEE ON SAFETY OF MEDICINES

http://www.mca.gov.uk/aboutagency/regframework/csm/csmhome.htm

MEMBERS HAVE DECLARED CURRENT PERSONAL AND NON-PERSONAL INTERESTS AS

FOLLOWS:

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Dr M Armitage None None

Professor D Ashby None Pfiers Statistical Talks No

Professor T R E Eli-Lilly Fees Sanofi-Synthelabo Grant Yes

CeNeS Consultancy

Pfizer Consultancy

Novartis Consultancy (clozapine)

Ms H Barnett None None

Professor A Blenkinsopp & -MS D Consultancy Servier )

Departmental Yes

Pfizer ) Research Yes

GSK ) Funding Yes

MSD ) Yes

Professor A Breckenridge None None

(Chairman)

Professor J Caldwell AstraZeneca Consultancy None

Schering-Plough Consultancy

Boots Healthcare Fees

Norton Healthcare Consultancy

Huntingdon Life Sciences Director

Pharmacia Consultancy

Amedis pharmaceuticals Director/Shareholder

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

120 C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l

a r a t i o n o f I n t e r e s t s

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Dr R Calvert None None

Dr T Chambers None None

Professor J Chipman Sci.Lucent McGhan Ltd Consultancy AstraZeneca )

Research Yes

GlaxoKline ) Grants Yes

Inamed Consultancy Syngenta Research Collaboration Yes

Professor J Darbyshire Genomyc Advisory Board Member Bristol-Myers

Squibb ) Support for Clinical Yes

GlaxoKline ) Trials eg. Salaries, Yes

Janssen Research Foundation ) running expenses, Yes

SLA Pharma, Osmetech ) consultancy, drugs, Yes

Roche ) reduced price pumps Yes

Merck ) and assays Yes

Unimed Pharmaceuticals US ) Yes

Eurpoean Society for ) Yes

Oncological & Immunological )

Research ) Yes

Gilead Sciences ) Yes

Pierre Fabre ) Yes

Pharmacia/Upjohn ) Yes

Chugai-Rhone-Poulenc ) Yes

Schering Plough ) Yes

Sanofi ) Yes

Aventis ) Yes

Wyeth & Wyeth-Ayerst ) Yes

Baxter ) Yes

Fresenius ) Yes

ML Labs ) Yes

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l a r

a t i o n o f I n t e r e s t s 121

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Professor J Darbyshire Interneuron ) Support for Clinical Yes

(continued) DuPont Pharma & Merck ) Trials eg. Salaries, Yes

Boehringer Ingelheim ) running expenses, Yes

Agouron ) consultancy, drugs, Yes

Virco ) reduced price pumps Yes

Chiron ) and assays Yes

Antisoma ) Yes

Lilly ) Yes

Intermune DSMC, Stiefel ) Yes

DSMC ) Yes

BMS Pharmacovigilance ) Yes

Professor H Dargie Servier Consultancy Merk AG Research Grant No

GlaxoKline Consultancy Novartis Research Grant Yes

Rhone-Poulenc Rorer Consultancy MSD Research Grant Yes

Chugai Consultancy Mitsubishi Research Grant Yes

Pharmacia Research Grant Yes

Meatronic Research Grant Yes

Dr M Donaghy Octapharma Honorarium for lecturing None

21 May 2001

GlaxoKline Shareholder

Professor G Duff Interleukin Genetics Inc, Scientific Advisory Board

Interleukin Genetics Inc Renewal of Yes

Boston (diagnostics Member and shares research contract

company) with Sheffield Uni.

Medical Solutions Plc, Scientific Advisory Board Shares to Sheffield

Uni.

Oxford (Mainly cancer Member and shares

diagnostics company) Stock Holding

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

122 C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l

a r a t i o n o f I n t e r e s t s

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Professor G Duff British Biotechnology Shares GlaxoKline New

Research Yes

(continued) Molecular Skincare Ltd, Shares/Director Contract with

Sheffield (Uni. of Sheffield spin- Sheffield Uni.

out company in skin research)

Dr B GlaxoKline Shares Galen Research Grant Yes

Boots Shares

Pharmacia Upjohn Fees

Professor S Eykyn None None

Dr J C Forfar GlaxoKline Shares Novartis Lecture to General No

Amersham Intl Shares Practitioners

Professor E Gordon- Bayer Plc Consultancy Chugai Research

Grants No

Toyama Europe Ltd Consultancy Amgen Research Grants No

Eli Lilly Consultancy Pfizer Research Grants No

Professor M Kendall None Menarini Dept Research Grant Yes

AstraZeneca Dept Research Grant Yes

Professor M Langman None Merck Sharpe Dohme Research support/ Yes

Consultancy

Norvartis Consultancy Yes

AstraZeneca Research Support Yes

Dr A V P Mackay None Laxendale Ltd Research Funding Lapsed

Support for a approx

consultant 1 year

colleague ago

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l a r

a t i o n o f I n t e r e s t s 123

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Professor H McGavock None None

Professor J Midgley Amylin Europe Limited ) Consultancy None

Mitsubishi Chemical (UK) )

Oxford Glycosciences )

Baxter SA )

FERX Inc )

Mallinckrodt Inc. )

Inex Pharm Corp )

Lonza Group )

Prof D Nutt GSK Consultancy/ Shareholding UCB Grant Yes

Janssen ) Consultancy GSK Grant Yes

Servier ) Wyeth Grant Yes

Esteve ) Pierre Fabre Grant Yes

Lundbeck ) Lundbeck Grant Yes

MSD )

AstraZeneca )

Wyeth ) Honoraria

Pierre Fabre )

Organon )

Professor B Park None Pfizer ) Advice Yes

Syngenta ) Yes

Glaxo Wellcome ) Yes

Professor J Petrie None None

(Co-Vice Chair)

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

124 C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l

a r a t i o n o f I n t e r e s t s

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

PDr J H Scarffe None None

Professor J F Smyth ISIS Pharmaceuticals Consultancy Novartis )

Clinical Trials Yes

Antigenics Consultancy Boehinger Mannheim ) Yes

Enchira Consultancy/ Shares British Biotech ) No

GlaxoKline Consultancy Eisai ) No

Pharma Mar Shares/ Consultancy Roche ) No

QLT Consultancy Knoll ) No

Abbott Consultancy AstraZeneca Fellowship Yes

Centocor – Non personal Clinical Trial Yes

specific

Professor T son Intercern Ltd Consultancy Abbott

Laboratories ) Fellowships

.. & Hanburys Ltd ) Meeting

Astra Respiratory ) Sponsorship

GlaxoKline ) University Yes

Merck Sharp Dohme ) Consultancy

Novartis Pharma AG ) Sponsorship of

Schering-Plough Ltd ) Departmental

Boots Healthcare Ltd ) Seminars

AstraZeneca ) Fellowships No

Aventis Pharma )

Cow & Gate Ltd ) Consultancy

Datex-Ohmeda Ltd ) Sponsorship of

Ferring Pharmaceuticals Ltd ) Departmental

Fisher & Paykel Healthcare Ltd ) Seminars

Mead Nutritionals ) Meetings No

Crookes Healthcare ) Sponsorship

Natus Neonatal Ltd )

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l a r

a t i o n o f I n t e r e s t s 125

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Professor T son Nestle UK Ltd ) Meetings

(continued) SMA Nutrition ) Sponsorship

3M Healthcare )

Wyeth Labs )

SHS International Ltd )

Sanofi Synthelabo )

Bristol Myers Squibb )

Dr R None None

Professor N Thomson None AstraZeneca Support for Clinical Yes

Trial

Professor I Weller None Gilead Sciences Co-chair of an Yes

oversight committee

GlaxoKline which is over-seeing Yes

a 5-6 million dollar

Boehinger Ingelheim program of research Yes

on the side effects

Merck of HIV drugs. Yes

This programme is

Roche supported by these Yes

listed companies.

Agouron In additional some Yes

of these companies

Abbott are sponsoring trials Yes

in Professor Weller's

dept. but he is not

Pharmacia Upjohn involved in the studies. No

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

126 C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l

a r a t i o n o f I n t e r e s t s

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Dr P Wilkie Consumer Health Information Consultancy with None

Centre (CHIC). Member of honorarium of £250

the advisory group which per meeting

is indirectly funded by the

member companies of the

Proprietary Association of

Great Britain (PAGB).

Group meets 2-3 times per

year. PAGB organises CHIC.

PAGB trade organisation

for OTC medicines.

CHIC does not know the

member companies.

Dr F None Unilever Research Grant Yes

Procter and Gamble Report Yes

Research Funding Research Grant Yes

Professor K Woodhouse None Aventis ) Clinical Research No

Alaz Corporation ) Trials No

Boehringer Ingleheim ) No

Eisai ) Yes

Eli Lilly ) Yes

Elan ) Yes

MSD ) Yes

Neotherapeutics ) No

Pharmicia/Upjohn ) No

Proctor/Gamble ) Yes

Shire ) No

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l a r

a t i o n o f I n t e r e s t s 127

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Professor K Woodhouse GlaxoKline ) Clinical Research No

(continued) Theramex Corporation ) Research Yes

Toyama ) No

Dr P Amersham Shares None

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

128 C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l

a r a t i o n o f I n t e r e s t s

CHEMISTRY, PHARMACY & STANDARDS SUB-COMMITTEE

MEMBERS HAVE DECLARED CURRENT PERSONAL AND NON-PERSONAL INTERESTS AS

FOLLOWS:

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Professor Pfizer Patent advice consultancy GlaxoKline )

Research Grant Yes

E Aulton Fees paid (Jan to Feb 2002) R P Scherer ) to Department Yes

Pfizer ) Yes

AstraZeneca ) Yes

Professor Graham British Biotech Consultancy AstraZeneca Research

Funding Yes

Buckton Generics UK Consultancy GlaxoKline Research Funding Yes

Eli Lilly Shares/Wife employed by Novartis Research Funding Yes

Company Pfizer Research Funding No

Schering Plough Consultancy Schering Plough Research Funding Yes

Elan Consultancy Norvatis Research funding Yes

Powderject Contract Research Yes

Studies

Norvatis Research Funding Yes

Cenes Research Funding Yes

ICI Research Funding Yes

(not pharmaceutical)

Prof H Calam None None

Dr T Calvert See entry under Committee on Safety of Medicines

Ms Judith A Cantrill None None

Dr J None Merck-Lipha ) Research Funding Yes

Pfizer ) Yes

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l a r

a t i o n o f I n t e r e s t s 129

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Dr J GlaxoKline ) Research Yes

(continued) Pharmacia ) Funding Yes

Convance ) Yes

Uniqema (ICI involved bulk ) Yes

drug and excipient manufacture )

ML Labs ) Yes

Dr Alastair G son None Abbott Labs No

Avecia Ltd No

Celltech Chiroscience No

Faulding Pharm No

Noprvartis Animal Health No

PathoGenesis Corp. No

Quintles, Scotland No

Vericore Ltd No

Cephalon UK No

CP Pharmaceuticals No

Merck & Co Inc. No

Pfizer No

Prometic Biosciences No

SKB No

Speywood Biopharm No

Professor D J G Davies Vectura Ltd Non Excutive Director/

AstraZeneca Yes

Consultant/ Shareholder Biogemma He was, until Sept. 01 Yes

Boots the Dean of the Yes

Britannia Pharmaceuticals Yes

Capsugel Faculty of Yes

Chiesi Farmaceutici Science, University Yes

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

130 C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l

a r a t i o n o f I n t e r e s t s

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Professor D J G Davies DERA of Bath, which has Yes

(continued) Glaxo Wellcome six departments. Yes

The companies listed

Nickerson BIOCHEM provide research Yes

ML grants or contracts to Yes

Miat academic staff within Yes

Novartis one or more of the Yes

Pfizer departments. The Yes

Ranbaxy Dean is not in Yes

Rotta receipt of any Yes

Rhône Poulenc Rorer grants from these Yes

R.P. Scherer DDS Companies, (except Yes

Serono those also listed in Yes

& Nephew the Personal Yes

Sterix Interests column), Yes

Syntex He is merely the Head Yes

Unilever Of the Faculty's Yes

Vanguard Administration Yes

Professor Biotec Laboratories Ltd Directorship, Shares,

Convance Clinicals/ ) Consultancy Yes

P Denyer Grants and Consultancy Reriaproval )

Kodak Ltd Consultancy Eschmann Equipment ) Yes

(lapsed Dec 2001) Superdrug Pharmacy ) Yes

Destiny Pharma Ltd Research sponsorship Colorcon Ltd ) Yes

Oxoid Research Sponsorship Custom Pharmaceuticals ) Training Yes

Unilever Research studentship GlaxoKline ) Yes

(lapsed Jan 2002) Sterilox Medical )

Procter & Gamble Research sponsorship Novo Nordisk ) Research Yes

Samo Research Sponsorship Astra Pharmaceuticals ) Grants Yes

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l a r

a t i o n o f I n t e r e s t s 131

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Professor Reckitt Benkisevr Research Grant Cellective

Sauflow ) Yes

P Denyer (continued) Biocompatibles Research Sponsorship

Pharmaceuticals )

Advanced Biotechnologies Research Sponsorship Abbott Labs ) Yes

JSD Technologies (dormant) Directorship Craig Medical Products ) No

Optometric Technology ) Yes

MSD ) Yes

BOC ) No

Shire Pharmacuticals ) Yes

APS/ Berk Pharmaceuticals Consultancy/ Yes

Training/ Donations

MBM Technology Consultancy/ Research Yes

Pfizer Donation No

Professor Ruth Duncan Pharmacia ) Milestone Payments/ Abbott Labs )

Sponsorship for Yes

Access Pharmaceuticals ) Royalties/ Prizes Access pharmaceuticals )

International Yes

Advanced Polymer systems ) Research Advnced Polymer Systems )

Conference in Yes

Eurand Inter. ) Amgen Inc ) January 2000 Yes

ML Labs ) Support Asta Medica ) Also requested for Yes

Xenova ) Aventis ) January 2002 Yes

Cell Therapeutics Inc ) BASF ) Yes

Daiichi ) Consultancy Bayer ) Yes

Bespak ) Consultancy Boehringer Ingelheim ) Yes

Syngenix ) Pending Cell Therapeutics ) Yes

GlaxoKline ) Yes

Hoffman La Roche ) Yes

Merk KgaA ) Yes

PolyMASC Pharmaceuticals ) Yes

Rhone Poulenc ) Yes

Schering ) Yes

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

132 C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l

a r a t i o n o f I n t e r e s t s

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Professor Ruth Duncan Transgene Inc ) Yes

(continued) Vectura Ltd ) Yes

Yamanouchi ) Yes

Dr Gillian M Eccleston Glaxo Wellcome Consultancy (product) Glaxo

Wellcome Student Grant Yes

Procter and Gamble Consultancy (product) 3M Student Grant Yes

Pfizer Postgraduate Student/ Yes

Post Doctoral Grant

Professor Halation Shares/ Fees Aventis Research

Contract Yes

Marriott MedPharm Shares/ Consultancy Sir Halley Trust

Research Contract Yes

Vectura Ltd Shares/ Consultancy GlaxoKline Research Contract Yes

Remedia Directorship MedPharm Ltd Research Contract Yes

Galephar Consultancy

Controlled Therapeutics Consultancy

Pfizer Consultancy

Aventis Consultancy

Dr A Meredith AstraZeneca Lecture Fees Pfizer Study grant Yes

GlaxoKline Lecture & Consultancy/ Fees

MSD Consultancy

Boehringer Ingelheim Lecture Fees, Consultancy

Pfizer Lecture Fees, Consultancy

Professor Midgley See Entry under the Committee on Safety of

Medicines

(Chairman)

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l a r

a t i o n o f I n t e r e s t s 133

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Prof D Thurston Spirogen Ltd Shares, Director, Grants None

Yan Ji Chemicals Shares, Director, Grants

Yanikem Shares, Director, Grants

Oxford Glyco Sciences Collaboration

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

134 C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l

a r a t i o n o f I n t e r e s t s

BIOLOGICALS SUB-COMMITTEE

MEMBERS HAVE DECLARED CURRENT PERSONAL AND NON-PERSONAL INTERESTS AS

FOLLOWS:

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Professor Gordon Duff See entry under the Committee on Safety of

Medicines

(Chairman)

Professor Calam None None

Dr Moira Bruce None None

Professor Christoper Bucke British Biotech Shares None

GlaxoKline Shares

..

Professor Mark Ferguson Cambridge Antibody Technology Shares Pfizer

Case Studentship Yes

Renova Co-Founder/ CEO/ Shares Renovo Case Studentship Yes

British Biotechnology Shares

Medical Solutions PLC Consultancy

& Nephew Research Grant Yes

Seton Scholl Research Grant Yes

AstraZeneca Research Grant Yes

Dr G F Hill None Baxter Honorarium for No

Organising Scientific

Meeting

Bayer Sponsorship to Attend No

2 Meetings

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l a r

a t i o n o f I n t e r e s t s 135

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Professor Jeffries None GlaxoKline Grant to department

Yes

to cover out of hours

advice to research

virologists

Professor Pedro AstraZeneca Consultancy AstraZeneca Research Grants

Yes

Lowenstein Genopoietic, Paris Scientific Advisory Board

Intronn Plc Scientific Collaboration

Gen Vec Scientific Collaboration

Emeritus Professor Celltech Shares None

Mitchison AstraZeneca Shares

GlaxoKline Shares

Professor North NeuroSearch AS Consultancy AstraZeneca Major

Grants

Sophion Consultancy

Neuromics Board of Directors,

Scientific Advisory Board

Transqeuomic Shares and Advisory Board

Professor S H Ralston Procter & Gamble Consultancy

Lilly Consultancy

Aventis Research Grant

Dr G C Schild None None

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

136 C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l

a r a t i o n o f I n t e r e s t s

PHARMACOVIGILANCE SUB-COMMITTEE

MEMBERS HAVE DECLARED CURRENT PERSONAL AND NON PERSONAL INTERESTS AS

FOLLOWS:

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Professor M Kendall None Menarini ) Dept Research Yes

AstraZeneca ) Grant Yes

Dr K Beard None None

Dr R Ferner Pfizer 1 Free Lunch None

Professor J M Hunt None None

Professor R H GlaxoKline/ ) Consultancy & Norvatis ) No

personal Support Yes

Glaxo Wellcome ) Speaker's Fees ) for two primary care

AstraZeneca ) Wyeth ) organisations – The Yes

Boots P/L Consultancy Fees ) PCSG and the ESPCG

Janssen Cilag ) in which he is involved Yes

Mrs A Lee None None

Dr T M Mac Pharmacia ) Consultancy, honoraria Aventis )

Commissioned Yes

Boehringer Ingelheim ) for Lectures Bristol-Myers Squibb ) Research

Yes

Novartis Trial Coordinator, GSK ) Yes

Consultancy, Honoraria Kotobuki ) Yes

for Lectures Eli Lilly ) Yes

Pfizer USA Consultancy Novartis Healthcare ) Yes

Novartis Healthcare Consultancy Novartis ) Yes

AstraZeneca Honoraria for Lectures Menarini ) Yes

Pfizer ) Yes

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l a r

a t i o n o f I n t e r e s t s 137

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Dr T M Mac Solvay Honoraria for Lectures Pharmacia )

Commissioned Yes

(continued) GSK (GlaxoKline) ) Expired Personal ) Research and

Lundbeck ) Conflicts (1 year ago) ) Research Fellowship

Roche No

MSD No

Wyeth No

Bayer No

Professor K McPherson Leryl, Day & Co Solicitors Consultancy on

action None

re 3rd Generation Oral

Contraceptives

Prof M Pirmohamed None Pfizer ) NPNS – Research Yes

Ask ) Grant Yes

Aventis ) Non Personal Yes

Bristol Myers Squibb ) Research Grant Yes

Merck Sharp and Dohme Ltd ) No

Professor P Routledge Healthcare Education Services Fees for

training of Roche ABPI Funded registrar Yes

Pharmaceutical Industry AstraZeneca ABPI Funded registrar Yes

Staff (Roche) for Dept Pharmacology,

Takeda Europe Research Consultancy Fees UWCM

Dr S H L Pfizer Consultancy Pfizer Research Grant Yes

Lundbeck Consultancy Kotobuici Research Grant No

AstraZeneca Research Grant Yes

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

138 C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l

a r a t i o n o f I n t e r e s t s

CSM/MCA EXTERNAL ADVISORY PANEL

MEMBERS HAVE DECLARED CURRENT PERSONAL AND NON PERSONAL INTERESTS AS

FOLLOWS:

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Dr L R I Baker None None

Dr D N Bateman None Jansssen-Cilag Education Grant for Yes

Research Fellow

Studying ethics of

Clinical Research

(Joint Supervisor).

AstraZeneca The Poisons Bureau Yes

provides Code- (On-going

Breaking service from

for them out of previous

hours years)

Dr J Bingham None Guerbet Departmental study Yes

of Pharmaceutical for

imaging lymph nodos in

head and neck cancer

Serono Departmental study of Yes

contrast for multiple

sclerosis

Prof R Buckley None Bausch/ Lomb Sponsorship of part- Yes

time academic post

at City Uni.

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l a r

a t i o n o f I n t e r e s t s 139

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Prof R D R Camp Novartis UK Consultancy (ongoing) None

re dermatological products

Schering-Plough ) One off paid consultancy

Powderject/ Akos ) in last year (skin related

) products)

Elan Pharmaceuticals One off unpaid consultancy

(favour for a friend)

Dr A J Cant Gilead Sciences Limited Educational Donation Grifols

Educational donation Yes

towards attendance at towards unit attendance

Espid meeting in Lithuania at EBMT meeting,

Aventis Pasteur Merieux Lecture fees Swizerland

MSD Ltd Gilead Sciences Educational donation Yes

towards CGD research

study

Prof I A Choonara None Astra Research Grant Yes

SSL International Advice for Res. Funds Yes

Interlern Advisor Yes

Boots Advice for Res. Funds Yes

Dr T Clutton-Brock None None

Prof S M Cobbe Bristol Myers Squibb Consultancy/ Grant Bristol Myers

Squibb Research Grant Yes

Procter and Gamble Consultancy

AstraZeneca Consultancy/ Lecture Fees

Boehringer Ingelheim Consultancy

Pfizer Consultancy

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

140 C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l

a r a t i o n o f I n t e r e s t s

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Dr J Compston Procter & Gamble Consultancy None

Eli Lilly Consultancy

Servier Consultancy

Norvatis Consultancy

Prof M Contreras None B P L Part of the NBS Yes

(NBS is her employer)

Baxter/Cerus Given advice and firm No

has sponsored the NBS

Haemonetics Given advice and firm No

has sponsored the NBS

Prof R W Cooke None None

Dr G M Boots Shares (67 in total) None

Prof D S Davies AstraZeneca Share Holder Servier R & D ) Commissioned

Yes

Services Labortories Consultancy GSK ) Research Yes

ML Labs Non-Exec Director AstraZeneca ) Yes

& Shareholder OSI Pharmaceuticals ) Yes

MSD ) Yes

Schering Healthcare ) Yes

Bristol Myers Squibb ) Yes

Mrs C Dealey None & Nephew Medical Commission for Yes

research work

Dr G B Drummond None AstraZeneca Project Overheads Yes

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l a r

a t i o n o f I n t e r e s t s 141

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Professor E Elias AstraZeneca Consultancy None

Norgine Consultancy/ Grant

Dr R Ferner Pfizer 1 Free Lunch None

Prof J lyn None None

Prof E Gale None None

Dr T Gibson None None

Dr A Glasier Leiras Consultancy – Reproductive Organon Grant No

medicine Schering Sponsorship Meeting Yes

GSK Shares

Dr C Grattan Schering Plough £800 for visiting Guest Schering Plough

Local Organiser allergy Yes

Lecture Fee, Copnehagen symposium March 2002

10/01 Ppt. Dernatology (£4000 sponsorship for

Meeting meeting expenses,

including Honorarium

for visiting speakers,

travel & accommodation

Prof C E M Griffiths Novartis Consultancy (Dermatology Novartis

Pharma ) Research Yes

Products) Agennix ) Grants Yes

Galderma ) Fujisawa ) Yes

Biogen ) Stiefel ) Yes

Centocor ) Consultancy Unilever ) Yes

Wyeth-Ayerst )

Stiefel )

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

142 C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l

a r a t i o n o f I n t e r e s t s

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Prof K Gull RBM (Italy) Consultancy None

Dr D Heaf None None

Dr P Hindmarsh GSK £400 consultancy on None

growth

Prof P D Home Novo Nordisk ) Consultancy Novo Nordisk ) Research

Grants / Yes

GSK ) GSK ) Projectsupport Yes

Aventis Pharma ) Aventis ) Yes

Pfizer Inc ) Pfizer ) Yes

Merck Inc )

Prof P Houghton Oxford Natural Products PLC Consultancy Higher

Nature Ltd Research Grant to No

Ancile Pharmaceuticals Consultancy Dept of Pharmacy

Beehealth Ltd Consultancy Stiefel Labs Research Grant to Yes

Dept of Pharmacy

Kinetique Research Grant to Yes

Dept of Pharmacy

Dr J Ironside Merck, USA Consultancy (for 1 day None

meeting)

Prof P Issacson None None

Prof D A Isenberg Celltech Consultancy – 80% donated Celltech )

Trial of an TRF and Yes

to arthritis research, 20% Knoll ) monodoral anitbody – Yes

he keeps for himself. ) pays for part-time

) research fellowship

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l a r

a t i o n o f I n t e r e s t s 143

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Prof D A Isenberg Hoechst n Roussel Paid for him to attend

(continued) the American College of

Rheumotology DFM in

San Francisco (Nov 2001)

Dr S B Kayne Labolife SA Spain Personal non-specific None

consultancy

Boots Company Personal training

consultancy

Dr C R Kennedy GSK Travel cost contribution Jansen-Cilag ) Grant

towards Yes

GSK ) salary

Norvatis Meeting expenses

Prof B J Kirby None None

Miss G Lachelin AstraZeneca Shares None

Prof I Lauder None AstraZeneca Research Project Yes

funding in our

Institution

Dr R J A Logan AstraZeneca Shares ( & Consultancy AstraZeneca Grants

Yes

as from Feb 2002)

GSK Shares

Merck Consultancy as from

Dec 2001

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

144 C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l

a r a t i o n o f I n t e r e s t s

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Prof R MacSween Kline Beecham Shares None

Medeva Share

Proteus Shares

Prof J O'D McGee Hoffman La Roche Consultancy None

Merck Shares

Pfizer Shares

SmitrhKline Beecham Shares

Prof I Mc Janssen Cilag Anti-dementia Consultancy/ Fees Janssen

Cilag Research Grant Yes

drugs Pfizer/ Eisai Research Grant Yes

Shire Pharmaceuticals Anti- Fees

dementia drugs

Novartis Anti-dementia drugs Fees

Pfizer Anti-dementia drugs Fees

Eisai Anti-dementia drugs Fees

Lilly Pharmaceuticals Anti- Fees

psychotics

Prof J McKillop None None

Dr E None North American Vaccine Grant to study Yes

(now Baxter Healthcare) meningococcal C

Wyeth Lederle Vaccines ) Grant to support post- Yes

Chiron Biocine ) licensure surveillance Yes

Baxter Health Care ) of meningococcal C Yes

) conjugate vaccine

Kline Beecham Grant to study Yes

meningococcal C

and HIB in infants

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l a r

a t i o n o f I n t e r e s t s 145

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Dr E Aventis Pasteur CMI testing in Yes

(continued) adolescent sera

Dr H Mitchison None None

Dr C Moss None Dermal Labs Sponsored Annual Yes

Dinner and

sponsorship

of educational

activities and

patient support

work

Crookes Health Care ) Sponsorship Recurrent

UCB Pharma ) of Educational Recurrent

Dermapharm ) activities and Recurrent

Dumex ) patient support Recurrent

Galderma ) work Recurrent

Nutragena ) Recurrent

Leo ) Recurrent

Quinoderm ) Recurrent

SSL International ) Recurrent

Stiefel Labortories ) Recurrent

Fujisawa Clinical Trial/ Fees Yes

Dr B R O'Driscoll AstraZeneca No Finiancial Interst, None

but they sponsored my

attendance at European

Respiratory Society

meeting in Berlin in

Sept 2001

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

146 C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l

a r a t i o n o f I n t e r e s t s

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Dr R J Pinney None None

Dr S A Qureshi Numed Inc, Hopkinton USA Royalty payments None

(Balloon Catheter)

Professor P Routledge Healthcare Education Services Fees for

training of Roche ABPI Funded registrar Yes

Pharmaceutical Industry

Staff (Roche)

Takeda Europe Research Consultancy Fees AstraZeneca ABPI Funded

registrar Yes

for Dept Pharmacology,

UWCM

Dr L Rylah None None

Prof R Seymour Pfizer Consultancy Reckitt Benkiser Grant No

AstraZeneca Grant Yes

Oraldent Grant Yes

Prof P J Shaw Amgen Principal Investigator None

Aventis Research Grant

Dr R Shearer None None

Prof S Shovron VCB Honorarium for Lecturing None

and travel expenses

and Advisoray board

membership

Dr P C C None None

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l a r

a t i o n o f I n t e r e s t s 147

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Prof S K Metris Therapeutics Director/ Shares/ Fees None

Schering Consultancy

Pfizer Consultancy

Dr N Soni Portex Limited Consultancy Nexstar Grant Yes

Pharmacia Consultancy National Blood Service Grant Yes

Novo Seron Consultancy

Prof S G Spiro Lilly Industries Grant to " London Lung None

Cancer Group " to fund

a national trust

Dr M s Chugai Pharma Received Travel grant to Chugai Pharma

Chairman of Yes

support cost of attendance International Clinical

at a scientific meeting Trial which receives

(£1000 in 2001) Grant support towards

data management costs

(Paid via the United

Kingdom Children's

Cancer Study Group)

Prof R D Sturrock Amgen Consultancy Amgen ) Commission Yes

Centocor ) for Research Yes

Roche ) Work No

Genmab ) Yes

Serono ) Yes

Dr P B Sullivan Nutricia Ltd Research Grant Yes

Norgine Ltd Research Grant Yes

SHS Ltd Travel Grant No

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

148 C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l

a r a t i o n o f I n t e r e s t s

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Dr R Tasker None Meed ston Ltd Travel Grant No

Dr R Thorpe None Amgen Grant (Contract) No

Prof G T Tucker Napp Consultancy GSK Res Student/ Research Yes

GSK Consumer Products Consultancy Consortium

Yamanochic Consultancy GSK Consumer Products Grant Yes

AstraZeneca Consultancy Pfizer Research Consortium Yes

Charnwood Consultancy AstraZeneca Research Consortium Yes

ML Labs Consultancy Norvatis Research Consortium Yes

Boots Healthcare Consultancy Synthelabo Research Consortium Yes

Pfizer Consultancy Cyprolex Research Consortium Yes

Teva Fees Novo Nordisk A/S Research Consortium Yes

Roche Fees

Dr M Tucker AstraZeneca Pension None

Mr A Tullo None Chauvin Payments per patients Yes

studied to Endowments

fund used principally for

Travel Grants for Junior

medical colleagues

AstraZeneca Collaborative work with Yes

Christie Hospital tending

to payments per patient

studied to Endowments

fund for purchases of

equipment for Eye Hospital.

MD travel grants for medical

and non medical staff to mtgs.

M e d i c i n e s A c t 1 9 6 8 A d v i s o r y B o d i e s A n n u

a l R e p o r t s 2 0 0 1

C o m m i t t e e o n S a f e t y o f M e d i c i n e s D e c l a r

a t i o n o f I n t e r e s t s 149

PERSONAL INTERESTS NON-PERSONAL INTERESTS

MEMBER NAME OF COMPANY NATURE OF NAME OF COMPANY NATURE OF WHETHER

INTEREST INTEREST CURRENT

Prof J C E Underwood Merck Consultancy (2001) Novartis Head of

department Yes

Medical Solutions Advisory Board/ Member in which a collegue

has support from

Novartis

Dr J H Walter None None

Prof D Warrell None None

Dr D C Wheeler Wyeth Pharmaceuticals Honoraria Amgen (UK)

Sponsorship of Yes

Novartis Honoraria a student

Amgen UK Ltd Fee Paid Work Genzyme Commission for No

Genzyme Consultancy research work

Bristol Myers Squibb Honararia Merck Sharpe & Dohme ) Support of

clinical Yes

Merck Sharpe & Dohme Honararia Schering Plough ) Trial Yes

Ortho Biotech Honararia

Prof G T Aphton Corporation Consultancy None

Prof N A None Byk Gulden Consultant on Yes

Educational

Programme

Sign In

COMMITTEE ON SAFETY OF MEDICINES members declared interests

Recommended Posts

Guest guest

Link to comment

Share on other sites

Guest guest

Link to comment

Share on other sites

Guest guest

Link to comment

Share on other sites

Guest guest

Link to comment

Share on other sites

Join the conversation

Activity